A functional study of the endocannabinoid system in zebrafish neurodevelopment: implications in vision and locomotion by Sepe, Rosa Maria
 
 
“FEDERICO II” UNIVERSITY OF  NAPLES 
 
 
 
 
VETERINARY SCIENCES PhD THESIS  
XXX CYCLE 
 
 
A functional study of the endocannabinoid system in 
zebrafish neurodevelopment: implications in vision 
and locomotion 
 
 
 
 
Candidate                                                       Tutors 
Rosa Maria Sepe                                      Dr. Paolo Sordino 
                                                        Prof. Paolo De Girolamo 
 
 
Coordination - Prof. Giuseppe Cringoli
   
INDEX 
List of abbreviations………………………….……………..……….page I 
List of figures………………………………………………………..page V 
List of tables……………………………………………………....page VIII 
1. Abstract……………………………………………………….….page 1 
2. Introduction………………....……………………………….…...page 4 
2.1. The Endocannabinoid System……………………………....page 4 
2.2. The Retrograde Signaling of Endocannabinoids…………...page 14 
2.3. ECS and Neurodevelopment…………………………….....page 17 
2.4. ECS and Locomotion………………………………………page 20 
2.5. ECS and Vision…………………………………………….page 24 
3. Zebrafish as Experimental Model………………………………page 29 
3.1. Neurogenesis in Zebrafish Embryos……………………….page 33 
3.2. Development of the Zebrafish Motor Behavior…………....page 36 
3.3. Neurogenesis in the Zebrafish Retina……………………...page 38  
3.4. Zebrafish to Study the ECS………………………………...page 44 
4. Thesis Aims…………………………………………………......page 50 
5. Results…………………………………………………………..page 52 
5.1. Temporal expression profile of ECS genes during  
zebrafish development……………………………………..page 52 
5.2. Analysis of endocannabinoid levels during zebrafish  
embryonic and larval developmental stages…………….....page 57 
5.3. Dagls and Magl enzymatic activities reflect increased  
2-AG turnover during embryonic development……………page 59 
5.4. Spatial-temporal characterization of ECS gene   
expression profiles……………………………………...….page 60 
5.5. Spatial-temporal characterization of 2-AG  
metabolic enzymes expression profiles……………….……page 61 
 
5.6. Spatial-temporal characterization of 2-AG  
main receptor expression profiles…………………….….. page 66 
5.7.  daglα down-regulation to decrease 2-AG levels……….....page 70 
5.8.  Role of Daglα in axon growth…………………………......page 75 
5.9.  Vision acuity and sensitivity in Daglα-deprived larvae….page 79  
5.10. Locomotor phenotype caused by Daglα depletion……...page 83 
5.11. Locomotor phenotype caused by  
cannabinoid receptors  antagonists…………………….....page 85 
5.12. The role of ECS in retinotectal axon guidance……….....page 90 
5.13. The role of CB2 in retinal lamination……………….......page 95 
5.14. Generation of zebrafish mutants for  
daglα and cnr1 by CRISPR/Cas9 Technology………..….page 100 
6. Discussions and Conclusions……………………………….....page 106 
7. Future Perspectives……………………………………………page 113 
8. Materials and Methods………………………………………..page 114 
8.1. Zebrafish maintenance and transgenic fish line………….page 114 
8.2. Quantitative PCR analysis……………………………….page 115 
8.3. Measurement of ECs AEA, 2-AG, and EC-like  
PEA and OEA from whole zebrafish………………….....page 115  
8.4. Magl and Dagls enzymatic activity studies  
on zebrafish embryos and larvae…………………………page 116 
8.5. RNA probes production………………………………….page 117 
8.6. Whole mount in situ hybridization (WISH)……………...page 120 
8.7. MO knockdown………………………………………..….page 121 
8.8. Pharmacological treatments and exposure windows…….page 123 
8.9. Whole mount immunohistochemistry……………………page 123 
8.10. Optokinetic response…………………………………….page 125 
8.11. Locomotor assays………………………………………..page 125 
8.12. Transgenic lines imaging……………………………….page 126 
8.13. Genome Editing using CRISPR/Cas9 Technology…….page 127 
8.14. Statistical analyses……………………………………...page 130 
9. References……………………………………………………..page 131 
 
 
  
I 
 
LIST OF ABBREVIATIONS 
2-AG, 2-Arachidonoylglycerol 
ABH4/6/12, α/β-hydrolase 4/6/12 
AC, amacrine cell 
AC, adenylate cyclase  
AEA, N-arachidonoylethanolamine 
BC, bipolar cell  
BDNF, brain-derived neurotrophic factor   
BMP, bone morphogenetic protein  
cAMP, Cyclic adenosine monophosphate 
Cas9, CRISPR associated protein 9  
cnr1/2 (gene) - CB1/2 (protein), cannabinoid receptor type 1/2 
CNS, central nervous system 
COX2, cyclooxygenase 2 
CRISPR, Clustered Regularly Interspaced Short Palindromic Repeats 
DAG, diacylglycerol 
daglα/β (gene) - Daglα/β (protein), diacylglycerol lipase α/β 
dpf, days post fertilization 
ECS, endocannabinoid system  
CB/eCB, cannabinoid/endocannabinoid 
eef1a1l1, eukaryotic translation elongation factor 1 alpha 1, like 1 
II 
 
EMT, endocannabinoid membrane transporter 
ERK, extracellular signal-regulated kinases 
FAAH, fatty acid amide hydrolase 
FGF, fibroblast growth factor  
GCL, ganglion cell layer  
GDE1, glycerophosphodiester phosphodiesterase 1 
GPCR, G protein-coupled receptor  
GPR18/55/119, G protein-coupled receptor 18/55/119 
gRNA, guide RNA 
HC, horizontal cell 
hpf, hours post fertilization 
INL, inner nuclear layer  
IPL, inner plexiform layer  
IP3, inositol 1,4,5-trisphosphate  
LTD, long-term synaptic depression  
LTP, long-term potentiation  
MAPK, mitogen-activated protein kinase  
mgll (gene) - Magl (protein), monoacylglycerol lipase 
mGluR, metabotropic glutamate receptor 
MO, morpholino  
MSN, medium spiny neuron  
III 
 
NADA, N-Arachidonoyl dopamine 
NAPE, N-arachidonoyl phosphatidylethanolamine  
NAPE-PLD,N-acyl-phosphatidylethanolamine-selective phosphodiesterase  
NAT, N-acyltransferase  
OEA, Oleoylethanolamine  
OKN, optokinetic nystagmus  
OKR, optokinetic response 
PA, phosphatidic acid  
PE, pigmented epithelium  
PEA, Palmitoylethanolamide  
PI3K, Phosphatidylinositol-4,5-bisphosphate 3-kinase 
PIP2, phosphatidylinositol-4,5-bisphosphate  
PKA/C, protein kinase A/C 
sPLA1/2, soluble phospholipase A1/2 
PLC, phospholipase C  
PLCβ, phospholipase Cβ  
PLD, phospholipase D  
PNS, peripheral nervous system 
POA, preoptic area  
PR, photoreceptor  
ptgs2b, prostaglandin-endoperoxide synthase 2b 
IV 
 
PTPN22, protein tyrosine phosphatase non-receptor type 22 
RGC, retinal ganglion cell 
RNE, retinal neuroepithelium    
RPE, retinal pigmented epithelium  
SC, superior colliculus  
SNL, superficial neuropil layer  
SoxB1, SRY-box containing genes B1 family  
STDP, spike-timing-dependent plasticity  
TALEN, Transcription activator-like effector nucleases  
TNP, tectal neuropil  
trpv1 (gene) - TRPV1 (protein), transient receptor potential vanilloid  
subtype 1 receptor 
WISH, whole mount in situ hybridization 
WNT, wingless/integrated   
  
V 
 
LIST OF FIGURES 
1. Molecular structure of main endocannabinoids…………….…......page 5 
2. Biosynthesis, action and inactivation of anandamide (AEA)  
 and 2-arachidonoylglycerol (2-AG)………………………………..page 6 
3. Subcellular localization of endocannabinoid metabolic  
  pathways…………………………………………………………page 16 
4. Levels of analysis of neural circuits controlling motor  
  behavior………………………………………………………..…page 22 
5. Adult male (left) and female (right) zebrafish……………………page 29 
6. Stages of zebrafish development…………………………………page 32 
7. Zebrafish central nervous system………………………………...page 35 
8. The chronological sequence of the appearance of motility  
patterns during development of the zebrafish…………...…….…page 37 
9. Similarity between the zebrafish and the human retina layers…...page 38 
10. Early morphogenetic events leading to the formation  
 of the optic cup………………………………………………….page 40 
11. Neurogenesis in the zebrafish retina……………………………page 41 
12. Structure of the retina……………………………………….......page 42 
13. Representation of zebrafish retinotectal projections……………page 43 
14. Strategies for providing toxicological and therapeutic  
 insights about cannabinoid biology using zebrafish……….……page 47 
15. ECS genes are expressed in zebrafish embryos and  
 larvae at levels that increase during development…...……....page 55-56 
16. eCB levels during zebrafish development....................................page 58 
VI 
 
17. Enzymatic activities of biosynthetic (DAGLs) and  
 catabolic (MAGL) 2-AG enzymes……………………………...page 59 
18. daglα and daglβ gene expression profiles during  
 zebrafish neurogenesis…………………………………………..page 62 
19. Dynamic expression of mgll during zebrafish neurogenesis..page 64-65 
20. cnr1 gene expression profile during zebrafish neurogenesis…...page 67 
21. Few neural and sensory cell types expressing trpv1…………....page 69 
22. Representation of oligo-Morpholino binding site………………page 71 
23. Dose-response relationship of oligo-morpholino……………….page 72 
24. Analysis of 2-AG levels in daglα and mgll morphants…………page 73 
25. RT-PCR analysis of embryos injected with  
 daglα-Sb1 and mgll-Sb1 morpholinos……………………..…....page 74 
26. Body morphology of daglα-Tb1 injected fish………………......page 75 
27. Loss of Daglα causes specific defects in axonal outgrowth….…page 78 
28. Schematic drawing of the setup used to  
 stimulate and record optokinetic responses……………………..page 81 
29. OKR is reduced in Daglα-deficient larvae……………………...page 81 
30. OKR is not compromised in Mgll-deficient larvae……………..page 82 
31. Locomotor phenotype in Daglα and Mgll-deficient larvae……..page 84 
32. Locomotion is impaired in Daglα-deficient larvae…..................page 84 
33. Molecular structure of cannabinoid receptors antagonists…...…page 85 
34. Phenotypic characterization of treated animals…………………page 86 
VII 
 
35. Locomotion is impaired in pharmacological treated  
 larvae at 72 hpf………………………………………………….page 88 
36. Locomotion is impaired in pharmacological treated  
 larvae at 5 dpf…………………………………………………...page 89 
37. Daglα-depleted embryos show aberrant RGC  
 projections at 5 dpf……………………………………………...page 92 
38. Daglα-depleted embryos have smaller tectal neuropil at 5 dpf…page 92 
39. RGC projections in treated larvae at 5 dpf……………………...page 94 
40. Tectal neuropil area in treated larvae at 5 dpf…………………..page 94 
41. SoFa transgenic line………………………………………….…page 96 
42. Trasversal sections of SoFa retina treated with  
 CB2 antagonist at 72hpf………………………………………...page 98 
43. Trasversal sections of SoFa retina treated with  
 CB2 antagonist at 5dpf………………………………………….page 99 
44. Representation of gRNAs binding sites in daglα gene………..page 102 
45. Representation of gRNAs binding sites in cnr1 gene…………page 103 
46. Electropherogram of the daglα mutated exon 2…………...….page 104 
47. Electropherogram of the daglα mutated exon 6……………….page 104 
48. Locomotion is impaired in daglα CRISPR/Cas9  
 larvae at 5 dpf………………………………………….……….page105 
 
 
 
VIII 
 
LIST OF TABLES 
1. Endocannabinoid levels in the adult retina of various species…...page 26 
2. Cannabinoid receptor type 1 protein distribution in the  
  adult retina of various species…………………………………....page 27 
3. Cannabinoid receptor type 2 protein distribution in the  
  adult retina……………………………………………………….page 28 
4. Summary of Zebrafish Endocannabinoid  
Gene Function Studies…………………………………………..page 48-49 
5. Quantitative PCR primer pairs used for ECS  
temporal dynamics during zebrafish development………………….page 54 
6. gRNA sequence 5‟-3‟……….…………………………………..page 101 
7. Enzymes for antisense riboprobes production………………….page 119 
 
 
 
 
 
 
1 
 
1. ABSTRACT:  
The endocannabinoid system (ECS) is constituted by a group 
of endogenous arachidonate-based lipids [endocannabinoids (eCBs)] and 
their receptors, capable of regulating neuronal excitability as well as a 
variety of physiological processes.  
The 2-Arachidonoylglycerol (2-AG) is a retrograde neurotransmitter 
present at relatively high levels in the central nervous system, with 
cannabinoid neuromodulatory effects on synaptic transmission in the adult 
brain. Recently, several lines of evidence have demonstrated the presence 
of eCBs, their receptors and metabolizing enzymes, also in early stages of 
brain development, suggesting an important role of ECS in the regulation 
of neural progenitor proliferation and specification as well as migration 
and differentiation. 
In this study we focus on the importance of 2-AG signaling in central 
nervous system development, with the aim to investigate the role of 2-AG 
in the development and differentiation of neurons, and in the formation of 
neuronal circuits that control spontaneous locomotion and visual system, 
using zebrafish as model organism. 
The vertebrate Danio rerio (zebrafish) represents a valid animal model 
system to study eCB biology, since phylogenetic analyses of the zebrafish 
ECS have demonstrated that it is highly conserved with the mammalian 
counterpart. 
Here we report the presence of a complete endocannabinoid system during 
zebrafish development and show that the genes coding for enzymes that 
catalyze the anabolism and catabolism (daglα and mgll respectively) of the 
endocannabinoid 2-AG, as well as its main receptor in the brain, 
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cannabinoid receptor type 1 (cnr1), are co-expressed in defined regions of 
neurogenesis and axogenesis.  
Through the use of morpholino-induced transient knockdown of the 
zebrafish daglα and its pharmacological rescue, we suggest that the 
synthesis of 2-AG is implicated in the control of axon formation in defined 
areas of the developing brain, such as optic tectum, cerebellum and optic 
nerve. Animals lacking Daglα display defective axonal growth and 
fasciculation, and abnormal physiological behaviors in tests measuring 
stereotyped eye movement and motion perception. Moreover the use of 
daglα morpholino in the zebrafish transgenic line 'ath5:gap-gfp', in which it 
is possible to follow the retinal ganglion cells (RGC) pathfinding, reveals 
abnormalities in RGC fiber tracts and in the correct arborization in the 
optic tectum. 
Furthermore, pharmacological treatments using antagonists of the two 
main zebrafish eCBs receptors (CB1 and CB2) suggest their putative role 
in the correct formation of the tectal neuropile in transgenic line 'ath5:gap-
gfp' and in the correct lamination of neuroretina in SoFa line, in which all 
the major retina neuronal subtypes are labeled simultaneously. 
In details, pharmacological treatments using antagonists of CB1 receptor 
suggest its putative role in the correct formation of the tectal neuropile in 
zebrafish transgenic line 'ath5:gap-gfp'. On the other hands, by using SoFa 
zebrafish line, in which all the major retina neuronal subtypes are 
simultaneously labeled, similar treatments highlight the possible role of 
CB2 in the correct lamination of neuroretina by regulating the number and 
positioning of interneurons (amacrine cells) in the inner plexiform layer of 
developing retina. 
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Animals treated with these antagonists display also defective swimming 
behavior, suggesting, in addition, the implication of CB1 and CB2 
receptors in the correct formation of neuronal circuits that control 
spontaneous locomotion. 
In conclusion, our results point to the important role of eCBs as mediators 
in axonal outgrowth with implications in the control of vision and 
movement, highlighting that the well-established role of 2-AG in axon 
guidance is required in brain areas that control locomotor and optokinetic 
functions. On the other hand, the eCBs receptors CB1 and CB2 can 
specifically regulate the formation of retinotectal system, the 
differentiation and lamination of zebrafish neuroretina, as well as direct the 
control of swimming behaviour. 
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2. Introduction 
2.1. The Endocannabinoid System 
The endocannabinoid system (ECS), known as "the body‟s own 
cannabinoid system" (Grotenhermen, 2012), is a complex endogenous 
regulation system that includes a large number of lipid and protein 
molecules, located throughout the central nervous system (CNS) and 
peripheral nervous system (PNS).  
The ECS, broadly speaking, includes: 
1. the endogenous arachidonate-based lipids, known as 
"endocannabinoids" (eCBs), that are physiological ligands for the 
cannabinoid receptors; 
2. the enzymes that synthesize and degrade the endocannabinoids; 
3. the cannabinoid receptors (Pertwee, 2006).  
eCBs are lipid molecules principally derived from membrane 
phospholipids. Unlike classical neurotransmitters and neuropeptides, eCBs 
are not stored in vesicles in axon terminals, but rather they are synthesized 
on site and on demand in somata and dendrites, in response to 
physiological or pathological stimuli, such as neuronal depolarization or 
high intracellular calcium levels. They are subsequently released from cells 
and then exert an immediate action as signaling molecules (Di Marzo, 
2008; Piomelli, 2003; Kondo et al., 1998). They act as neuromodulators, 
not directly as neurotransmitters but rather increase or decrease the action 
of neurotransmitters, tuning in this way the neural circuitry of an entire 
brain region; not just that of an individual neuron. 
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Several eCBs have been identified in brain and peripheral tissues, but their 
function and role in ECS physiology remains to be determined. They are 
all eicosanoids and their structures are summarized in Fig. 1.  
 
Figure 1: Molecular structure of main endocannabinoids.  
 
The best characterized eCBs are: 
 N-arachidonoylethanolamine (AEA), commonly known as 
anandamide (from Sanskrit word ananda, which means “bliss”), 
that was the first eCB to be identified by Lumír Ondřej Hanuš and 
William Anthony Devane in 1992 (Devane et al., 1992),  
 2-arachidonoylglycerol (2-AG), discovered as chemical compound 
by Shimon Ben-Shabat at Ben-Gurion University (Pizzorno, 2011), 
and described as an endogenous agonist for the cannabinoid 
receptors in 1994-1995 by a research group at Teikyo University 
(Sugiura et al., 1994; Sugiura et al., 1995). The 2-AG, was the 
second endocannabinoid to be discovered and it is the most 
abundant eCB present in the brain (Reisenberg et al., 2012).    
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These two eCBs are synthesized and degraded by separate pathways (Fig. 
2).  
 
Figure 2: Biosynthesis, action and inactivation of anandamide (AEA) and 2-
arachidonoylglycerol (2-AG). The biosynthetic pathways for AEA and 2-AG are 
shown in blue, degradative pathways are shown in pink. ABH4/6/12, α/β-
hydrolase 4/6/12; CB1/2, cannabinoid receptor 1/2; COX2, cyclooxygenase 2; 
DAG, diacylglycerol; EMT, endocannabinoid membrane transporter; FAAH, fatty 
acid amide hydrolase; GDE1, glycerophosphodiester phosphodiesterase 1; 
GPR55, G protein-coupled receptor 55; MAGL, monoacylglycerol lipase; NAPE-
PLD, N-acyl-phosphatidylethanolamine-selective phosphodiesterase; NATs, N-
acyltransferases; PA, phosphatidic acid; sPLA1/2, soluble phospholipase A1/2; 
PLC, phospholipase C; PLCβ, phospholipase Cβ; PLD, phospholipase D; 
PTPN22, protein tyrosine phosphatase, non-receptor type 22; TRPV1, transient 
receptor potential, vanilloid subtype 1 receptor. Taken from: Di Marzo, 2008 
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The major route for the biosynthesis of anandamide is via the precursor N-
arachidonoyl phosphatidylethanolamine (NAPE), which is generated by 
the enzyme N-acyltransferase (NAT) in a calcium-sensitive and -
insensitive  manner. AEA is then generated by hydrolysis of NAPE by four 
possible alternative pathways, the most direct of which (direct conversion) 
is catalysed by a phospholipase D (NAPE-PLD) (Di Marzo, 2008; 
Piomelli, 2003; Sugiura et al., 2002; Wang et al., 2009). Thus the 
endocannabinoid anandamide seems to be produced “on demand” and 
released in an activity-dependent manner by enzymatic cleavage of lipid 
precursors. The biological inactivation of anandamide occurs mainly 
through hydrolyzation mediated by fatty acid amide hydrolase (FAAH) 
(McKinney et al., 2005).   
The major pathway for the biosynthesis of 2-AG comprises sequential 
hydrolysis of arachidonic acid-containing inositol phospholipids by 
phospholipase C (PLC) and diacylglycerol (DAG) lipase (DAGL) (Di 
Marzo, 2008; Piomelli, 2003; Sugiura et al., 2002). In response to many 
extracellular signals such as neurotransmitters, PLC catalyzes the 
hydrolysis of phosphatidylinositol-4,5-bisphosphate (PIP2), thereby 
generating two well established second messengers, inositol 1,4,5- 
trisphosphate (IP3) and DAG. Two different DAGL, α and β, hydrolyze 
DAG to yield 2-AG. Different studies strongly suggest that DAGLα, rather 
than DAGLβ, is the predominant 2-AG synthesizing enzyme for 
endocannabinoid-mediated modulation of neurotransmission (Gao et al., 
2010; Tanimura et al., 2010; Yoshino et al., 2011), while DAGLβ is more 
implicated in inflammatory responses in macrophages and microglia (Hsu 
et al., 2012; Viader et al., 2016). 2-AG, like AEA, is transported into 
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neurons by endocannabinoid membrane transporters (EMT), such as heat 
shock proteins (Hsp70s) and fatty acid binding proteins (FABPs) 
(Kaczocha et al., 2009), and is subsequently inactivated by the enzyme 
monoacylglycerol lipase (MAGL) (Di Marzo, 2008; Piomelli, 2003; 
Sugiura et al., 2002). 2-AG is also metabolized to some extent by other 
recently identified lipases, the α/β-hydrolases 6 (ABH6) and 12 (ABH12), 
as well as FAAH, but MAGL is responsible for ~85% of this activity in the 
brain (Savinainen et al., 2012).  Both AEA and 2-AG, possibly under 
conditions in which the activity of MAGL or FAAH is suppressed, might 
become substrates for cyclooxygenase 2 (COX2) and give rise to the 
corresponding hydroperoxy derivatives. AEA and 2-AG hydroperoxy 
derivates can then be converted to prostaglandin ethanolamides 
(prostamides) and prostaglandin glycerol esters, respectively, by various 
prostaglandin synthases (Rouzer et al., 2008). 
2-AG synthesis and release can be driven by activation by Gq-coupled 
receptors, such as group I mGluRs (metabotropic glutamate receptors) and 
muscarinic receptors, because the signaling pathway that they activate 
leads to accumulation of the 2-AG precursor DAG (Alger et al., 2002; El 
Manira et al, 2008; Kano et al., 2009; Kettunen et al., 2005).  In summary, 
the synthesis and release of these two endogenous cannabinoids occurs on 
demand in an activity-dependent manner either in terms of firing of 
neurons or activation of Gq-coupled receptors, or a combination of the two. 
Separate synthesis and degradation pathways of AEA and 2-AG offer an 
entry point for determining their distribution and for defining their roles in 
controlling CNS functions. 
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All eCBs have in common the ability to bind to cannabinoids receptors, the 
same receptors that interact with phytocannabinoids. 
Two cannabinoid receptors, cannabinoid receptor type 1 (CB1) and type 2 
(CB2), have been identified pharmacologically, anatomically, and by 
molecular cloning, but other cannabinoid receptors may exist, with 
different tissue distribution and signaling mechanisms (Mackie et al., 
2006). 
CB1 receptor is a G protein-coupled receptor (GPCR) from the 
cannabinoid receptor family that in humans is encoded by the cnr1 gene. 
These receptors are expressed virtually throughout the CNS and PNS from 
cortical to spinal cord regions (Katona et al., 2008). They are also present 
in minor amounts in some peripheral organs and tissues including lungs, 
liver, kidneys and digestive system. At the brainstem, the distribution of 
CB1 receptors is particularly marked in the regions responsible for motor 
coordination and movement, attention, and complex cognitive functions 
such as judgment, learning, memory and emotions (Herkenham et al., 
1990; Mailleux et al., 1992; Pettit et al., 1998). CB1 receptors may exist as 
homodimers or form heterodimers or other GPCR oligomers when 
coexpressed with one or more classes of G-protein-coupled receptors. They 
are predominantly localized on presynaptic terminals, at glutaminergic and 
GABAergic interneurons, acting as neuromodulators in a retrograde 
manner to inhibit release of glutamate and GABA (Elphick et al., 2001), 
but there are also reports of a postsynaptic localization on dendrites and 
neuronal somata (Marsicano et al., 2003). These receptors were initially 
thought to be coupled preferentially to a Gi/o G-protein, which decreases 
intracellular cAMP concentration by inhibiting its production enzyme, 
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adenylate cyclase (AC), and increases mitogen-activated protein kinase 
(MAP kinase) concentration. Alternatively, recent data show that they can 
be also coupled to Gq G-protein to induce release of Ca
2+
 from 
intracellular stores, and to Gs proteins, which stimulate adenylate cyclase 
(Pertwee, 2006). cAMP is known to serve as a second messenger coupled 
to a variety of ion channels, including the positively influenced inwardly 
rectifying potassium channels (Kir or IRK) (Demuth et al., 2006) and 
calcium channels, which are activated by cAMP-dependent interaction 
with such molecules as protein kinase A (PKA), protein kinase C (PKC), 
Raf-1, ERK, JNK, p38, c-fos, c-jun, and others (Pagotto et al., 2006).  
CB2 receptor is also a G protein-coupled receptor that in humans is 
encoded by cnr2 gene and it is closely related to cnr1, with a protein 
sequences identity of 44% (Latek et al., 2011). CB2 receptors are 
expressed primarily at the peripheral level, mainly on T cells of the 
immune system, on macrophages and B cells, and in hematopoietic cells. 
Further investigation into the expression patterns of the CB2 receptors 
revealed that CB2 receptor gene transcripts are also expressed on 
peripheral nerve terminals, on some rat retinal cell types (López et al., 
2011), and in the brain, though not as densely as the CB1 receptor and 
located on different cells (Onaivi, 2006). Unlike the CB1 receptor, in the 
brain, CB2 receptors are found primarily on microglia (Cabral, 2008) and 
in some neurons within the central nervous system (e.g. brainstem), where 
their role remains not well defined (Mackie et al., 2006; Sickle et al., 
2005). While the most likely cellular targets and executors of the CB2 
receptor-mediated effects of endocannabinoids or synthetic agonists are the 
immune and immune-derived cells (e.g. leukocytes, various populations of 
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T and B lymphocytes, monocytes/macrophages, dendritic cells, mast cells, 
microglia in the brain, Kupffer cells in the liver, astrocytes, etc.), the 
number of other potential cellular targets is expanding, now including 
endothelial and smooth muscle cells, fibroblasts of various origins, 
cardiomyocytes, and certain neuronal elements of the peripheral or central 
nervous systems (Pacher et al., 2011). 
Like CB1 receptors, CB2 receptors inhibit the activity of adenylyl cyclase 
through their Gi/Goα subunits. It is also known that CB2 receptors are 
coupled to the MAPK-ERK pathway through their Gβγ subunits 
(Shoemaker et al., 2005; Demuth et al., 2006; Bouaboula et al., 1996), 
regulating a number of important cellular processes in both mature and 
developing tissues (Shvartsman et al., 2009). Activation of the MAPK-
ERK pathway by CB2 receptor agonists, acting through the Gβγ subunit, 
results also in changes in cell migration (Klemke et al., 1997), as well as in 
an induction of the growth-related gene Zif268 (also known as Krox-24, 
NGFI-A, and egr-1) (Bouaboula et al., 1996), implicated in neuroplasticity 
and long-term memory formation (Alberini, 2009). 
Different pharmacological data suggest that additional cannabinoid 
receptors may be present in the CNS (Járai et al., 1999; McHugh et al., 
2008). 
Molecular biology studies have suggested that the G protein-coupled 
receptor GPR55, first identified as an orphan receptor, should in fact be 
characterized as a cannabinoid receptor, on the basis of sequence 
homology at the binding site (Baker et al., 2006), but with a signaling 
profile distinct from CB1 and CB2 receptors (Mackie et al., 2006). 
Subsequent studies showed that GPR55 does indeed respond to 
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cannabinoid ligands (Ryberg et al., 2007; Johns et al., 2007). This profile 
as a distinct non-CB1/CB2 receptor which responds to a variety of both 
endogenous and exogenous cannabinoid ligands, has led some groups to 
suggest that GPR55 should be categorized as the CB3 receptor, and this re-
classification may follow in time (Overton et al., 2006; Ross, 2009; Kapur 
et al., 2009; Moriconi et al., 2010). 
Along with GPR55, GPR18 and GPR119 have been also implicated as 
novel cannabinoid receptors. 
Recent research strongly supports the hypothesis that the N-Arachidonyl 
glycine receptor (NAGly receptor), also known as G protein-coupled 
receptor 18 (GPR18) is the molecular identity of the abnormal cannabidiol 
receptor and additionally suggests that NAGly, the endogenous lipid 
metabolite of AEA initiates directed microglial migration in the CNS 
through activation of GPR18 (McHugh et al., 2010).  
G protein-coupled receptor 119, also known as GPR119, is expressed 
predominantly in the pancreas and gastrointestinal tract in rodents and 
humans, as well as in the rodent brain, with a role in reduction in food 
intake and body weight gain (Overton et al., 2006), and in incretin 
regulation and insulin hormone secretion (Ning et al., 2008; Swaminath, 
2008; Lan et al., 2009).  
Transient receptor potential vanilloid 1 (TRPV1), also known as the 
capsaicin receptor, is a nonselective cation channel expressed mainly in the 
nociceptive neurons of the PNS, but it is also described in many other 
tissues, including the CNS (Caterina et al., 1997). TRPV1 receptors are 
involved in the transmission and modulation of pain (nociception), as well 
as the integration of diverse painful stimuli (Cui et al., 2006; Huang et al., 
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2002). These receptors are activated by a wide variety of exogenous and 
endogenous physical and chemical stimuli, sending a pain signal to the 
brain. The best-known activators of TRPV1 are: capsaicin, the irritating 
compound in hot chili peppers, heat, proinflammatory substances and 
acidic conditions. Interestingly, anandamide and other endocannabinoids, 
like N-oleyl-dopamine, and N-arachidonoyl-dopamine, are activators of the 
TRPV1 channel. Since sensory neurons often co-express both CB1 and 
TRPV1, they could regulate pain sensation in the brain, with potential 
implications in the treatment of inflammatory disorders (Ross, 2003). 
Thus, it is thought that cannabinoid signaling in the brain is mediated 
primarily by CB1 receptors, but that additional receptors may also be 
present. In addition, the anatomical localization of the receptors in relation 
to the site of synthesis and release of endocannabinoids will determine the 
direction of their signaling and physiological function, like motor control, 
memory and learning, pain perception, energy balance regulation, food 
intake, endocrine function, vascular response, immune system modulation, 
and neuroprotection. 
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2.2 The Retrograde Signalling of Endocannabinoids 
In the study of synaptic transmission, the field of endocannabinoid 
research is flowering. A wealth of recent findings has revealed critical 
molecular underpinnings of endocannabinoid generation and signal 
transduction, and the subcellular localization of these processes within 
neurons has been mapped with increasing detail. Sophisticated techniques 
of neuronal imaging and electrophysiological recording are combined to 
yield new insights into the timing and regulation of endocannabinoid 
signaling at synapses throughout the brain, and these discoveries are 
beginning to influence models of synaptic computation and plasticity at a 
profound level (Gerdeman, 2008). 
Endocannabinoids are now known to act as a widespread system of 
retrograde signaling at central synapses, whereby the stimulus-dependent 
synthesis of endocannabinoids in postsynaptic neurons leads to the 
activation of presynaptic CB1 receptors, and a subsequent inhibition of 
neurotransmitter release via multiple presynaptic mechanisms. 
In fact, multiple lines of evidence have led to general consensus that in 
many brain areas, the molecular synthetic pathways for AEA and 2-AG 
exert their function postsynaptically to both excitatory and inhibitory 
synapses (Matyas et al., 2006; Katona et al., 2006; Yoshida et al., 2006) 
(Fig. 3).  
Postsynaptically released endocannabinoids that are triggered by 
membrane depolarization, intracellular Ca
2+
 elevation, and/or activation of 
Gq/11-coupled metabotropic receptors, act at presynaptic CB1 receptors to 
mediate retrograde synaptic inhibition at both excitatory and inhibitory 
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synapses, and on timescales that are either transient (on a scale of seconds) 
or long lasting. 
Accordingly, endocannabinoids in the CNS intervene in both short-term 
and long-term forms of synaptic plasticity, including depolarization-
induced suppression of both excitatory and inhibitory neurotransmission, 
long-term potentiation and depression, and long-term depression of 
inhibition (Wilson et al., 2002; Freund et al., 2003). 
Multiple lines of evidence including localization of CB1 receptors on 
presynaptic terminals (Herkenham et al., 1991; Egertova et al., 1998; 
Katona et al., 1999), preferential coupling to Gi/o proteins (Howlett et al., 
2002), and inhibition of voltage-gated Ca
2+
 channels (VCCs) (Twitchell et 
al., 1997; Shen and Thayer, 1998), indicate that endocannabinoids would 
cause suppression of vesicular neurotransmitter release. 
By dynamically modulating synapse reliability, synaptic suppression 
mediated by endocannabinoids provides a means for postsynaptic neurons 
to “tune” the sensitivity of their synaptic inputs to afferent patterns of 
stimulation. This mechanism may in turn help to regulate burst firing, or to 
generate or maintain synchronous membrane oscillations in interconnected 
neuronal populations. Endocannabinoid-dependent long-term synaptic 
depression (LTD) has also been recently demonstrated to underlie multiple 
forms of spike-timing-dependent plasticity (STDP) in the cerebral cortex, 
long thought to regulate the neuronal representation of sensory maps.  
In many ways, the activity and functional potential of a neural circuit is 
defined by the moment-to-moment state of its many synapses (Hebb, 1949; 
Bear, 1996; Abbott and Regehr, 2004). In recent years, the 
endocannabinoids have emerged as a system for modulating synaptic 
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efficacy within many brain areas, by acting as postsynaptically released 
retrograde messengers to presynaptic CB1 receptors. Short- and long-term 
synaptic suppression by CB1 receptors is a widespread mechanism to fine-
tune synaptic filtering properties, and to facilitate associative modes of 
plasticity as a coincidence detector. In addition, endocannabinoid-mediated 
LTD has now redefined many known forms of synaptic plasticity, 
clarifying these processes on a new level of mechanistic detail.  
The endocannabinoid system is thus central to many cellular mechanisms 
of stable neuronal plasticity, information that has wide-ranging 
implications for understanding brain function and the etiology and 
treatment of neurological diseases. 
                          
 
Figure 3: Subcellular localization of endocannabinoid metabolic pathways. 
This overview highlights potential factors controlling the physiology of 2-AG or 
AEA at postsynaptic sites of generation and release, as well as presynaptic 
signaling by CB1 receptors (CB1). Taken from: Di Marzo et al., 2004. 
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 2.3 ECS and Neurodevelopment 
Endocannabinoids act as retrograde messengers that control synaptic 
plasticity, that is the ability of the nervous system to alter the functional 
efficiency of neuronal connections (synapses), to establish new ones and to 
eliminate some others. This mechanism occurs in many areas of the 
postnatal brain, including neocortex, hippocampus, cerebellum, and basal 
ganglia.  
But, besides this well-established neuromodulatory role in adults, it has 
just begun to emerge that the endocannabinoid signaling also subserves 
fundamental mechanisms of CNS development: this family of lipid 
mediators is pivotal in controlling neurogenesis, neuronal progenitor 
proliferation and fate specification, lineage segregation, neuronal 
migration, differentiation and survival, influencing the formation of 
complex neuronal circuits in the embryonic brain that directly translate into 
retrograde synaptic signaling once synapse establishment concludes 
(Fernandez-Ruiz et al., 2000; Fride, 2004; Harkany et al., 2008). 
Neuroanatomical findings furnish the concept that the endocannabinoid 
system is expressed and positioned during CNS development such that its 
activity can ideally tune a broad array of developmental processes in both 
neural progenitors and in lineage-committed neuronal precursors. 
During brain development, the expression of CB1, CB2, GPR55 and 
TRPV1 receptors, and enzymes associated with endocannabinoid synthesis 
and degradation coincides with the expansion of neural progenies and their 
engagement in establishing neuronal diversity (Galve-Roperh et al., 2006; 
Harkany et al., 2007). The presence of functional endocannabinoid 
signaling networks in neurogenic proliferative zones of the developing 
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brain, and also in neurogenic niches of the adult, suggests that 
endocannabinoid signals could provide extracellular cues instructing the 
cellular program of neural progenitors such that they generate appropriate 
contingents of cell lineages required to build the developing brain (Aguado 
et al., 2005). The endocannabinoids and related lipid mediators regulate 
neural progenitor commitment and survival, guaranteeing a fine-tuned 
balance between progenitor cell proliferation and programmed cell death 
thus leading to the generation of adequate quantities of neural cells during 
brain development (Guzman et al., 2002; Guzman, 2003; Aguado et al., 
2006).  
The concept that on-demand endocannabinoid signaling links axonal 
specification in the early embryonic brain to synaptogenesis and synaptic 
plasticity during the neonatal period is supported by recent evidence 
identifying endocannabinoids as a novel class of axon guidance cues 
(Berghuis et al., 2007). An attractive hypothesis is that autocrine 
endocannabinoid signaling regulates growth cone differentiation and axon 
guidance (Bisogno et al., 2003). This concept stems from the finding that 
2-AG stimulates neurite outgrowth of cerebellar neurons via a mechanism 
dependent on intrinsic DAGLα/β activity within axonal growth cones 
(Williams et al., 2003). Also the activation of CB1 receptor controls neurite 
outgrowth and synaptogenesis, processes that are required to generate 
functionally mature neurons. In fact, the CB1 localization in developing 
brain has recently been identified as a prerequisite for guiding the 
elongating axons to their targets, and to achieving proper synapse 
positioning of postsynaptic target cells (Berghuis et al., 2007). 
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Furthermore the endocannabinoid effects also extend to the regulation of 
neuronal migration, and the attainment of particular morphological, 
physiological, and molecular phenotypes occurring during terminal 
neuronal differentiation. Notably, endocannabinoid-induced neuronal 
migration (Song and Zhong, 2000) acts in cooperativity with brain-derived 
neurotrophic factor (BDNF), a prime migration (Fukumitsu et al., 2006) 
and prodifferentiation factor (Ventimiglia et al., 1995; Horch and Katz, 
2002; Dijkhuizen and Ghosh, 2005), for a variety of CB1 receptor-
expressing neurons, including GABAergic, serotonergic, and dopaminergic 
cells. 
Finally, on-demand recruitment of second messengers to the CB1 receptor, 
e.g., the Src/Stat3 (Jordan et al., 2005; He et al., 2005), extracellular 
signal-regulate kinase (ERK1/2) (Galve-Roperh et al., 2000; Rueda et al., 
2002; Berghuis et al., 2007), and PI3K/Akt pathways (Molina-Holgado et 
al., 2002), and the modulation of sphingolipid-derived signaling mediators 
and cell death pathways (Guzman, 2003), enhances the ECS potential to 
dynamically regulate fundamental developmental processes, including 
neural progenitor proliferation and migration, fate decision, survival, and 
lineage specification, in a spatially and temporally coordinated manner 
(Harkany et al., 2007; Galve-Roperh et al., 2007).  
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2.4 ECS and Locomotion 
Motor behavior represents the overt expression of integrated CNS 
processing. The final motor output is the result of a sophisticated 
integration of the activity of different CNS networks, that display a 
continuous plasticity to allow their activity to adapt to changes in the 
internal and external environments (Destexhe and Marder, 2004). The 
plasticity of neural circuits can be changed by modulatory systems that 
have been classically considered to depend on release of modulatory 
transmitters from pre-synaptic terminals that can act post-synaptically on 
axon terminals or dendrites to change synaptic strength (Katz and Frost, 
1996; Nusbaum et al., 2001). This view has been revised following the 
discovery of retrograde signaling (Ohno-Shosaku et al., 2001), and the 
eCBs represent a prominent example of retrograde signaling in synaptic 
plasticity in many regions of the CNS. Most studies of eCB-mediated 
plasticity in the brain have concentrated on mechanisms related to learning 
and memory (Chevaleyre et al., 2006; Heifets and Castillo, 2009; Kano et 
al., 2009), but they have been confronted with the difficulty of quantifying 
cognitive changes in the aim to link synaptic plasticity with behavior. A 
major advantage of motor circuits is that their outputs can be readily 
measured and correlated to the motor behavior. Activity-dependent 
changes in synaptic efficacy play a critical role in shaping the functional 
architecture of neural circuits and determining their operational range. In 
this regard, eCBs have attracted much attention in recent years because of 
their unconventional way of regulating synaptic transmission. 
One region of the CNS where the link between eCB-mediated synaptic 
plasticity can be directly related to circuit function and motor behavior is 
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the spinal cord. Locomotor movements are generated by spinal networks 
comprised primarily of interconnected populations of excitatory 
glutamatergic and inhibitory glycinergic interneurons that lead to the 
temporally sequenced muscle contractions underlying locomotion. 
Because eCBs can in principle be released from all neurons in the spinal 
locomotor networks, they provide an important modulatory mechanism 
that is not only involved in fine-tuning of the ongoing activity but that may 
be also necessary for the generation of the locomotor activity (Fig.4). 
In vitro studies have demonstrated that eCBs play an important role in 
setting the baseline locomotor frequency. The blockade of CB1 receptors, 
in the isolated spinal cord, using a specific antagonist, reduced the baseline 
frequency of the locomotor rhythm, showing that eCBs are released within 
the locomotor circuitry and that they contribute to the expression of the 
motor pattern (Kettunen et al., 2005; Kyriakatos and El Manira, 2007; 
Thorn Perez et al., 2009). This indicates that activation of CB1 receptors 
by eCBs released during locomotion, regulates inhibitory and excitatory 
synaptic transmission in such a manner as to increase the excitability in the 
spinal circuitry and thus to accelerate the locomotor behavior (El Manira et 
al., 2008; Kettunen et al., 2002; Kyriakatos and  El Manira, 2007). 
Also the basal ganglia are thought to be responsible for the selection of 
appropriate motor behavior. They consist of a set of interconnected nuclei 
with the striatum as the primary input nucleus receiving excitatory inputs 
from cortex and thalamus and a dense dopaminergic innervation from 
midbrain nuclei.  
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Figure 4: Levels of analysis of neural circuits controlling motor behavior. A 
defined motor behavior is generated by networks of excitatory and inhibitory 
neurons. The activity of the neurons and their synaptic interactions is modulated 
by G-protein-coupled receptors that can be activated by endocannabinoids. Taken 
from: El Manira and Kyriakatos, 2010. 
 
The vast majority of neurons in the striatum are GABAergic medium spiny 
neurons (MSNs), with a few cholinergic and other GABAergic 
interneurons. The excitatory input to MSNs displays a strong activity-
dependent plasticity in the form of LTD and long-term potentiation (LTP). 
The striatal LTD requires the elevation of Ca
2+
 levels in postsynaptic 
neurons and a convergence of modulatory inputs activating group I 
mGluRs and dopamine receptors D2 (Kreitzer and Malenka, 2008; 
Surmeier et al., 2009). This combination of several signals leads to release 
of eCBs from MSNs that act retrogradely to depress synaptic transmission 
from excitatory terminals. The treatment with eCB degradation inhibitors 
in animals with depleted dopaminergic innervation significantly enhanced 
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locomotor activity. These results provide evidence that eCB-mediated 
synaptic plasticity in the striatum can be important in controlling motor 
function. However, it should be noted that eCB signaling cannot alone be 
responsible for balancing the activity of the direct and indirect pathways 
because other mechanisms are also necessary for the normal function of the 
basal ganglia circuitry and selection of motor behavior (Surmeier et al., 
2009).  
Finally, the cerebellum plays an important role in fine-tuning of motor 
behavior and in learning of new motor tasks, contributes to the precision 
and smooth execution of motor tasks, and furthermore mediates motor 
learning in the vestibulo-ocular reflex pathway (Ito, 1972). Purkinje cells 
are the only output from the cerebellar cortex and project to the deep 
cerebellar nuclei. Each Purkinje cell receives excitatory inputs from many 
parallel fibers arising from granule cells and from a single climbing fiber 
originating in the inferior olive. Excitatory synaptic transmission to 
Purkinje cells displays both short and long-term changes that depend on 
release of eCBs and activation of CB1 receptors. eCBs have been shown to 
mediate depolarization-mediated suppression of both inhibitory and 
excitatory synaptic transmission to Purkinje cells (Diana et al., 2002; 
Kreitzer and Regehr, 2001; Yoshida et al., 2002).  
Although endocannabinoid-mediated plasticity has been studied 
extensively in the cerebellum, very little is known about its significance for 
cerebellar function and motor behavior. To understand the function of 
endocannabinoid-mediated plasticity in terms of motor function, the 
analysis needs to be broadened from single synapses to circuit operation 
and ultimately to behaviorally relevant tasks. 
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2.5 ECS and Vision 
In the last decade, there has been a growing interest for eCBs in the retina 
and their role in visual processing and perception, and recent reports 
suggest that the ECS could play an instrumental role at all levels of the 
visual system. But the vast majority of these studies focused on the 
expression and functions of the ECS in the adult retina and visual system, 
and only a few investigated the expression and functions during embryonic 
development. 
Physiological and biochemical studies demonstrated the presence of the 
ECS in various ocular tissues. The presence of different eCBs and the 
expression profiles of CB1 and CB2 receptors in the adult retina of various 
species are summarized in Tables 1, 2 and 3. 
Most of the studies comparing AEA to 2-AG expression in the adult retina 
concluded that 2-AG levels are significantly higher than AEA (Chen et al., 
2005; Bisogno et al., 1999), and found that the content of eCBs varies in 
certain disease states, suggesting the importance of eCBs in maintaining 
ocular homeostasis (Chen et al., 2005; Matias et al., 2006).  
In the retina and in the primary visual cortex, cannabinoids act inhibiting 
the release of various neurotransmitters. Indeed, it has been found that CB1 
receptor agonists decrease the release of noradrenaline and dopamine via a 
Gi/o-dependent mechanism (Schlicker et al., 1996; Weber and Schlicker, 
2001; Savinainen and Laitinen, 2004), and can regulate the glutamate 
release in photoreceptors and bipolar and ganglion cells (Yazulla, 2008). 
Some evidence also suggests a regulatory effect on GABAA receptor-
mediated inward currents by CB1/CB2 receptor agonists in amacrine cells 
(Warrier and Wilson, 2007). Moreover, in vivo electrophysiological studies 
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indicate that CB2 receptor appears to cause changes light responses in the 
mouse retina (Cécyre et al., 2013).  
Taken together, these various effects may suggest a possible cannabinoid-
mediated tone in transmitter release. 
So far, few studies have looked at the effects of eCBs on retina 
development. Most works are based on the study of the expression profile 
of different eCBs receptors and metabolic enzymes in different animal 
species, and few others showed the functional impact of cannabinoids on 
retinal development. 
It has been reported that CB1 and CB2 receptor specific agonists induce a 
collapse of the growth cone of retinal ganglion cells and decrease axon 
growth (Argaw et al., 2011; Duff et al., 2013). Conversely, the application 
of CB1 and CB2 receptor specific inverse agonists increases the growth 
cone surface area and the number of filopodia present on the growth cone 
and increases axon growth.  
GPR55 also modulates growth rate and target innervation of retinal 
projections during development. For instance, the application of GPR55 
agonists increases the growth cone surface area and the number of 
filopodia and also triggers axon growth (Cherif et al., 2013). 
Furthermore, gpr55
−/−
 mice revealed a decreased branching in the dorsal 
terminal nucleus and a lower level of eye-specific segregation of retinal 
projections. Altogether, these studies identify a mechanism by which the 
ECS modulates retino-thalamic development and offer a potential model to 
explain why cannabinoid agonists affect CNS development. 
In summary, CB1 and CB2 receptors are both present in various retinal 
tissues where they modulate neurotransmitter release in the most part via 
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retrograde signaling, and where they inhibit potassium and calcium 
currents. These effects can thus modulate visual activity as early as at the 
retina level. More studies are obviously needed to assess to what extent a 
cannabinoid-mediated modulation in the retina could impact visual 
perception. This is especially true given that cannabinoid receptors are 
present in most retinal cell types. As cannabinoids are also present in the 
visual cortex, it may well be that cannabinoids modulate visual perception 
at each level of visual system hierarchy. 
Furthermore, as it has been previously demonstrated in the CNS, 
cannabinoids play an important role in neuronal development and axon 
guidance. It would now be of interest to see if a similar variation in the 
concentration of receptors, enzymatic machinery, and endogenous ligands 
occur also during retinal development.  
 
Table 1: Endocannabinoid levels in the adult retina of various species. 
Endocannabinoids Concentration (pmol/g) Species 
2-arachidonoyl glycerol (2-AG) 
2,970 
1,393 
1,600 
Rat 
Human 
Bovine 
Anandamide (AEA) 
Under detection level 
36 
64 
Rat 
Human 
Bovine 
Palmitoylethanolamide (PEA) 
130 
200 
Rat 
Human 
Oleoylethanolamide (OEA) 55 Rat 
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Table 2: Cannabinoid receptor type 1 protein distribution in the adult retina 
of various species. 
Retinal cell types Sub-cellular localization 
Photoreceptors 
Expression in the inner and outer segments 
Strong labeling in the cone pedicles 
Horizontal cells 
Expression in the membrane but not in 
dendrites 
Bipolar cells 
Expression in the dendrites, cell body, and 
axons of rod bipolar cells 
Amacrine cells 
Expression in amacrine cells, including 
GABAergic amacrine cells 
Inner plexiform layer 
Unspecified expression in the IPL 
Expression in the synapses of rod bipolar 
cells 
Higher expression in the synapses of ON 
cone bipolar cells compared to OFF cone 
bipolar cells 
Ganglion cells Expression in the cell body and fibers 
Müller cells 
Absence of expression 
Expression in the goldfish retina only 
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Table 3: Cannabinoid receptor type 2 protein distribution in the adult retina. 
Retinal cell types Sub-cellular localization 
Photoreceptors 
Expression in the outer and inner segments of 
cones 
Absence of expression in cone pedicles 
Expression in the inner and outer segments 
and cell body of rods 
Horizontal cells Expression at the membrane of the soma and 
in horizontal cells, dendrites 
Bipolar cells 
Expression in the membrane of the soma and 
axons of rod bipolar cells 
Expression in the membrane of the soma of 
cone bipolar cells 
Amacrine cells Expression in some subtypes 
Ganglion cells Expression in the soma 
Müller cells 
Absence of expression at the membrane of the 
soma, in Müller cells, inner and outer 
processes 
Expression in Müller cells‟ processes in the 
vervet monkey only 
Tables 1-2-3: Adapted from: Bouchard et al., 2015. 
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3. Zebrafish as Experimental Model 
Danio rerio, better known as zebrafish, is a small tropical fresh water fish, 
belonging to the Cyprinidae family and native to the Gange region in 
eastern India. It commonly inhabits streams, canals and other slow moving 
or stagnant water bodies but it is also widely sold as an aquarium fish 
(Mayden et al. 2007). It is so called because of a characteristic pattern of 
blue-black horizontal stripes that run along the body and in the anal and tail 
fins.  
Zebrafish reach sexual maturity at around three months of age and exhibit 
sexual dimorphism, with the female characterized by a larger belly and the 
male by its comparative slimness and a more yellowish hue (Fig. 5). 
Ever since George Streisinger pioneered his research using zebrafish in 
Eugene, at the University of Oregon in 1972, this fish species has become 
a great animal model both in basic and biomedical research. 
 
 
Figure 5: Adult male (left) and female (right) zebrafish. 
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Being a vertebrate, zebrafish share a high degree of genomic sequence and 
functional homology with mammals, including humans. Due to the 
conservation of cell biological and developmental processes across all 
vertebrates, studies in fish can help understanding protein functions and 
human disease processes. However, the genetic similarity to mammalians 
is not the only relevant reason to choose zebrafish as research model. A 
leading motive is for sure the optical transparency of zebrafish embryos, 
making them ideally suited for microscopic imaging of live processes. The 
fertilization of eggs is external, avoiding animal sacrifice as in case of 
murine models, and, in each spawn, zebrafish give a large number of 
offspring (200 embryos per mating) that develop relatively fast, ensuring a 
big and ready supply of animals for research purposes.  
Fluorescent markers can be also used to „light up‟ different cells and 
organs in the embryo giving the possibility to follow the impact of a 
genetic manipulation or pharmacological treatment using non invasive 
imaging techniques. Importantly, many simple and highly efficient genetic 
manipulation techniques have been developed (like zinc-finger, TALEN, 
CRISPR/Cas9, TOL-2), that allow targeted mutagenesis or generation of 
transgenic lines.  
Moreover, zebrafish embryos are able to absorb many chemicals by simple 
dissolution of them in the embryo medium, thus representing a useful tool 
for drug screenings.  
Zebrafish can thus contribute significantly to meeting the challenge of the 
post-genome sequencing era to understand gene function on a global scale. 
Its value as model has been further increased significantly by parallel 
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developments in microscopy technologies, which now allows us imaging 
intact live embryos at subcellular resolution. 
Another reason for the popularity of the zebrafish among the 
developmental biologists is the rapid development of its transparent 
embryos (Fig. 6). 
Cell divisions begin soon after the fertilization process and, during the 
blastula period, epiboly takes place, when cells proliferate, thinning and 
starting to coat the yolk. This stage ends at 30% epiboly. Epiboly goes on 
with the following period of gastrula stage, ranging from 5 to 10 hours post 
fertilization (hpf). During this developmental stage, cell induction 
movements of convergence and extension take place, leading to the 
formation of mesoderm, ectoderm and endoderm. It is also possible to 
recognize the anterior (that will generate the head) from the posterior (that 
will generate the tail) part of the main body axis, the ventral from the 
dorsal and medial tissue from the lateral ones. This stage is followed by the 
segmentation period, so called because of segmentation of the nervous 
system. Furthermore, the formation of somites, which are the structures 
giving rise to the trunk muscles, and sketches of the different organs are 
also evident. Embryo is fully transparent up to 22 hpf, by which stage, the 
melanocytes start to differentiate and the embryo begins to be pigmented. 
Movements are irregular and non-controlled. Major organ systems are 
formed over the next 24 to 36 hours. In the pharyngula period (24-48 hpf), 
the formation of the pharynx occurs, the head is extended and the pectoral 
fins are formed. The hatching period is the last embryonic phase, when the 
embryo exits the chorion (membrane surrounding the zygote) and the 
embryonic development is completed. After hatching, the embryo becomes 
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a free-swimming larva wherein all anatomical structures are fully 
established (Kimmel et al., 1995). 
 
Figure 6: Stages of zebrafish development.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
33 
 
3.1 Neurogenesis in Zebrafish Embryos 
Neurogenesis describes the process by which undifferentiated neural 
progenitor cells generate mature and functional neurons. The first steps in 
neurogenesis are the induction of neural progenitors and a phase of cell 
division that enlarges the pool of progenitors. This is followed by a 
sequence of events leading to specification of committed progenitors, and 
differentiation of post-mitotic neurons. Each of these steps is spatially and 
temporally orchestrated to generate the multiple neuronal and glial cell 
types that will eventually populate the mature CNS. The zebrafish has 
proven to be an excellent model organism to study neurogenesis, providing 
many contributions in neural development.  
The first phase in the development of the vertebrate nervous system is 
called “neural induction” and is initiated during early embryonic 
development. At the onset of gastrulation, the forming mesodermal layer 
involutes and comes into contact with the overlying ectoderm, inducing or 
inhibiting neural induction in the ectodermal layer (Doniach and Mushi, 
1995; Lumsden and Krumlauf, 1996; Spemann and Mangold, 2001; Streit 
et al., 2000), due to complex interactions between extrinsic (e.g. bone 
morphogenetic protein, BMP; wingless/integrated, Wnt; fibroblast growth 
factor, Fgf) and intrinsic factors (e.g. SRY-box containing genes B1 
family, SoxB1) (Streit et al., 1997; Avilion et al., 2003). Once specified, 
the neural ectoderm forms the neural plate, a pseudostratified epithelial 
structure in zebrafish. During the process of neurulation in zebrafish, 
unlike other vertebrates, the neural plate forms a solid neural keel instead 
of folding up immediately into a tube with a lumen. However, the 
topological arrangement of cells in zebrafish during formation of the neural 
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keel from the neural plate is similar to that of other vertebrates. In the so-
called “secondary neurulation”, the fish neural rod inflates and forms a 
typical vertebrate tube. Thus, although there are differences between 
mammals and fishes, neurulation leads to the formation of a highly similar 
structure: the neural tube (Papan et al., 1999). Three primary vesicles 
develop in the rostral portion of the neural tube: the prosencephalon 
(forebrain), mesencephalon (midbrain) and rhombencephalon (hindbrain). 
The caudal neural tube remains undifferentiated and will form the mature 
spinal cord. Secondary vesicles emerging from the prosencephalon give 
rise to the telencephalon (cerebral hemispheres) and diencephalon 
(thalamus and hypothalamus) (Fig. 7). The fish brain represents the 
anterior portion of the CNS: (antero-posteriorly) from a forebrain region 
(telencephalon and diencephalon), through the midbrain with its swellings 
(optic lobes), to the hindbrain (cerebellum and medulla). Subsequently, the 
CNS continues toward the caudal fin with the spinal cord. The 
mesencephalon or midbrain of fishes is relatively large; it consists of the 
optic tectum dorsally, appearing in dorsal view as two optic lobes, and the 
tegmentum ventrally (Lagler et al., 1967). 
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Figure 7: Zebrafish central nervous system. (A) Organization of the brain 
territories at neural plate stage. The groups of cells giving rise to each territory are 
shown in different colors. (B-D) The same color code is used to show the relative 
positions of the different territories in embryonic brains at a later stage of 
development, from lateral (B), dorsal (C) and ventral (D) views. Taken from 
Cavodeassi et al., 2009. 
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3.2 Development of the Zebrafish Motor Behavior 
Developmental patterns of network organization, including that of the 
locomotor network, are common among all vertebrates (Butler and Hodos, 
1996; Stein et al., 1997). Cellular and molecular principles and 
mechanisms underlying neuronal specification by transcription factors 
(Jessel, 2000) and axon guidance (Tessier-Lavigne, 1996) during early 
development have also been revealed.  
The zebrafish is a useful model for developmental studies and, especially, 
offers the possibility of studying the developmental genetics of the 
locomotor network in the living embryos (Brustein et al., 2003). The motor 
activity of the developing zebrafish changes and newly appearing 
behavioral traits are specific to different developmental stages. The 
stereotypic movements of developing zebrafish include three subsequent 
phases (Fig. 8):  
- a transient period of alternating coilings (~17 hpf), which exhibits two 
types of network-driven episodic activity. The first one represents a 
periodic depolarization that trigger action potentials and generate coils, 
while the second one originates bursts of glynergic inputs (synaptic 
events). However, the role of these bursts at this stage has not yet been 
clarified (Saint-Amant and Drapeau, 2000; Brustein et al., 2003).   
- a touch response (~21 hpf), characterized by an over-the-head and fast 
coiling of the trunk. This was suggested as the embryonic manifestation of 
the mature escape response (Saint-Amant and Drapeau, 1998; Eaton et al., 
2001; Brustein et al., 2003).  
- finally, the appearance of organized swimming, in which the swimming 
rate increases gradually. Newly hatched larvae (two-three days post 
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fertilization, dpf) are generally inactive, with only occasional episodes of 
spontaneous “burst” swimming, and by three-four dpf the larvae switch to 
a “beat-and-glide” mode of swimming (Saint-Amant and Drapeau, 1998; 
Buss and Drapeau, 2001; Brustein et al., 2003). 
 
 
Figure 8: The chronological sequence of the appearance of motility patterns 
during development of the zebrafish. Taken from Brustein et al., 2003. 
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3.3 Neurogenesis in the Zebrafish Retina 
As in other vertebrate species, the zebrafish retina is simpler than other 
regions of the central nervous system. This relative simplicity along with 
rapid development, and accessibility to genetic analysis make the zebrafish 
retina an excellent model system for studies of neurogenesis in the 
vertebrate CNS. 
The remarkable evolutionary conservation of the vertebrate eye provides 
the basis for using the zebrafish as a model system for the detection and 
analysis of genetic defects potentially related to human eye disorders. In 
fact, the zebrafish possesses a canonical vertebrate retina (Fig. 9) 
composed of one glial cell type (Müller glia) and six neuronal cell types 
distributed in three nuclear layers separated by two synaptic (plexiform) 
layers already apparent at 3 dpf. 
 
Figure 9: Similarity between the zebrafish and the human retina 
layers. 
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An important advantage of the zebrafish retina for genetic and 
developmental research is that it forms and becomes functional very early 
in development, indeed it is essentially complete by 60 hpf (Nawrocki, 
1985) and, as judged by the startle and optokinetic responses, the zebrafish 
eye detects light stimuli surprisingly early, starting between 2.5 and 3.5 dpf 
(Clark, 1981; Easter and Nicola, 1996). 
The optic lobes become evident during neurulation (12.5 hpf) as bilateral 
thickenings of the anterior neural keel, that gradually become more and 
more prominent and protrude laterally on both sides of the brain (Schmitt 
and Dowling, 1994) (Fig. 10 A-C). 
At approximately 13 hpf, the posterior portion of the optic lobe starts to 
separate from the brain, while its anterior part remains attached, forming 
later the optic stalk (Fig. 10 D). As its morphogenesis advances, the optic 
lobe turns around its antero-posterior axis so that its ventral surface 
becomes directed toward the brain while the dorsal surface starts to face 
the outside environment (Fig. 10 G).  
At ca. 15 hpf, cells migrate from the medial to lateral epithelial layer of the 
optic lobe (Fig. 10 G) (Li et al., 2000). The medial layer becomes thinner 
and subsequently differentiates as the retinal pigmented epithelium (RPE) 
(Fig. 10 H-K). At about the same time, an invagination forms on the lateral 
surface of the optic lobe (Schmitt and Dowling, 1994), accompanied by the 
appearance of the lens rudiment. 
Subsequently, over a period of several hours, both the invagination and the 
lens placode become increasingly more prominent, transforming the optic 
lobe into the optic cup (Fig. 10 J-L).  
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Figure 10: Early morphogenetic events leading to the formation of the optic 
cup. Taken from: Avanesov and Malicki, 2004. 
 
Starting at about 24 hpf, melanin granules appear in the cells of the 
pigmented epithelium, and at the beginning of day 2, the optic cup consists 
of two closely connected sheets of cells: the pseudostratified columnar 
neuroepithelium (RNE) and the cuboidal pigmented epithelium (PE) 
(Fig.11 A) (Kimmel et al., 1995; Schmitt and Dowling, 1994). The optic 
stalk gradually becomes less prominent and provides support for the axons 
of ganglion cells that begin to differentiate. 
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Lastly, the optic cup rotates around its mediolateral axis, and this rotation 
is the final major morphological transformation in zebrafish eye 
development (72 hpf), with the complete differentiation of the optic nerve 
(Macdonald et al., 1997). 
  
 
Figure 11: Neurogenesis in the zebrafish retina. (A) A section through the 
zebrafish eye at approximately 36 hpf, when the retina mostly consists of two 
epithelial layers: the pigmented epithelium and the retinal neuroepithelium.  (B) A 
section through the zebrafish eye at 72 hpf, when neurogenesis is mostly 
completed. The major nuclear and plexiform layers, as well as the optic nerve and 
the pigmented epithelium, are well differentiated. gcl: ganglion cell layer; inl: 
inner nuclear layer; ipl: inner plexiform layer; le: lens; mz: marginal zone; on: 
optic nerve; opl: outer plexiform layer; pcl: photoreceptor cell layer; pe: 
pigmented epithelium; rne: retinal neuroepithelium. Taken from: Avanesov and 
Malicki, 2004. 
 
As the morphogenetic movements that shape and orient the optic cup come 
to completion, the first retinal cells become postmitotic and begin to 
differentiate. Gross morphological characteristics of the major retinal cell 
classes are very well conserved in all vertebrates. Six major classes of 
neurons arise during neurogenesis together with the Müller glia: ganglion, 
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amacrine, bipolar, horizontal, interplexiform, and photoreceptor cells, 
taking place in different layers of the retina (Fig. 12). 
 
 
Figure 12: Structure of the retina. A: Microphotograph of a cross-section 
through the retina of an adult zebrafish, showing the different cellular and 
synaptic retinal layers. B: Diagram of the neural circuit of the retina, showing the 
six neuronal cell-types and the two supporting cell types (Müller glia and retinal 
pigmented epithelium). Taken from: Gramage et al., 2014. 
 
The neuronal network of the retina is largely self-contained. The only 
retinal neurons that send their projections outside are ganglion cells. At ca. 
36 hpf, their axons start to exit the eye and navigate through the midline of 
the ventral diencephalon into the dorsal part of the midbrain, the optic 
tectum (Burrill and Easter, 1995; Macdonald and Wilson, 1997).  
After crossing the midline, the axonal projections of ganglion cells split 
into the dorsal and ventral branches of the optic tract. The ventral branch 
contains mostly of axons of the dorsal retinal ganglion cells, the dorsal 
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branch being mostly composed of axons of the ventral retinal ganglion 
cells (Baier et al., 1996). The growth cones of retinal ganglion cells first 
enter the optic tectum between 46 and 48 hpf, when the spatial coordinates 
of retina and tectum are reversed. The ventral-nasal ganglion cells of the 
zebrafish retina project to the dorsal-posterior optic tectum; whereas the 
dorsal-temporal cells innervate the ventral-anterior tectum (Fig. 13) 
(Stuermer, 1988; Karlstrom et al., 1996; Trowe et al., 1996). By 72 hpf, 
axons from all quadrants of the retina are in contact with their target 
territories in the optic tectum. Moreover, zebrafish have topographic tectal 
afferents connecting directly from the zebrafish cerebellum. The deep 
layers of the tectum have topographic outputs to the hindbrain and can 
send output commands to motor centers, initiating swimming, hunting, and 
escape behaviors with respect to the location of the stimuli. In this manner, 
the tectum combines sensory inputs and rapidly generates survival 
behaviors in response to visual stimuli.  
 
Figure 13: Representation of zebrafish retinotectal projections.  
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3.4 Zebrafish to Study the ECS 
The complexity of how eCB signaling regulates the activity of circuits 
within the CNS is further obscured by the promiscuous signaling dynamics 
that are characteristic of this system. Numerous genes have been identified 
that provide alternate routes of eCBs degradation or synthesis, thereby 
resulting in region-specific ligand signaling profiles (Ahn et al., 2008; Di 
Marzo, 2011). Moreover, in addition to cannabinoid receptor 1 and 
cannabinoid receptor 2, eCBs bind to many non-CB receptors, that 
comprise a complex multipartite signaling system where a host of ligands 
bind to multiple receptors with differential affinities (Alexander and 
Kendall, 2007). Finally, the effects of eCBs receptors signaling depend on 
the specific cell type involved, which may be associated with opposing 
outcomes such as the inhibition or excitation of a neural circuit.  
These complicated dynamics that define eCBs signaling, coupled with the 
increasing use and development of exogenous CBs that differentially target 
this system, mandates scientific investigation of the toxicological and 
therapeutic potential of altered CB signaling. To this end, many research 
groups have sought to use the unique advantages of different model 
organisms to further explore eCB biology. Although the bulk of eCB 
literature published to date consists of experiments using in vitro 
approaches or rodent models, zebrafish have recently gained traction as a 
powerful in vivo model for complementing and expanding upon the 
findings of these existing studies. One useful application of zebrafish is 
pharmacological screening in a whole vertebrate system, well suited for 
rapidly assessing the effects of exogenous CB exposure.  
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Zebrafish are able to absorb small molecules across the skin from the 
surrounding water at all stages of development and even in adulthood. In 
addition, the fecundity of adult mating pairs, which can produce clutches of 
several hundred offspring per week, readily enables high-throughput 
screening.  
Due to the diverse scope of physiological processes that involve eCB 
signaling, zebrafish could be also used to identify novel therapeutic 
strategies. Exogenous CBs could be screened using disease models to 
identify compounds that corrected the pathological phenotypes of interest. 
Moreover, zebrafish are highly amenable to genetic manipulation, and are 
well suited for both reverse and forward genetic screening applications, 
representing an additional tool for the investigation of individual ECS gene 
functions.  
In recent years, developments in genome editing techniques have enabled 
precise and highly efficient modification of the zebrafish genome 
(Blackburn et al., 2013). Custom nuclease technology such as transcription 
activator-like effector nucleases (TALENs) and clustered regularly 
interspersed short palindromic repeat/Cas9 (CRISPR/Cas9) may be used 
for targeted mutagenesis of loci via non-homologous end joining, or the 
incorporation of new sequences using small single stranded 
oligonucleotide donors for homology directed repair (Blackburn et al., 
2013; Campbell et al., 2013). This technology has provided an accessible 
methodology for studying the roles of individual genes in the zebrafish 
model. With regard to eCB biology, establishing zebrafish lines with 
mutations in individual genes will be indispensable for studying their 
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function in this organism, which could be obscured by the potential off-
target effects associated with pharmacological investigations.  
Although zebrafish can significantly advance the understanding of eCBs 
biology with the use of pharmacological or genome editing approaches, the 
greatest contribution of this small model verterbate to the field will likely 
result from studies enabled through combined approaches (Fig.14).  
Any observed alterations in physiology or behavior could then be linked to 
specific molecular signaling cascades, which could be ideally analyzed 
with the use of comprehensive methodologies such as RNA sequencing 
and behavioral assays. 
Phylogenetic analyses of the zebrafish ECS have demonstrated that it is 
highly conserved with the mammalian counterpart, and ontogenetic 
analyses have revealed that ECS gene expression begins early in zebrafish 
development. In addition to the conservation of ECS genes themselves, 
many of the zebrafish ECS gene expression patterns also appear to be 
homologous. For instance, cnr1 and dagla are co-expressed in the 
zebrafish brain (Watson et al., 2008) and exhibit homologies with rodent 
distribution patterns as early as 2 dpf, which are maintained into adulthood 
(Lam et al., 2006; Ahn et al., 2008).  
For these reasons, zebrafish have already been used to study eCBs biology 
in diverse contexts including addiction, anxiety, development, energy 
homeostasis and food intake, immune system function, and learning and 
memory (summarized in Table 4). Nevertheless, the only study on 
zebrafish neural development was performed by Watson et al. (2008), 
showing that knockdown of cnr1 gene activity by morpholino antisense 
oligonucleotides resulted in defects of axonal growth and fasciculation. 
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Figure 14: Strategies for providing toxicological and therapeutic insights 
about cannabinoid biology using zebrafish. Taken from: Krug II et al., 2015. 
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Table 4: Summary of Zebrafish Endocannabinoid Gene Function Studies
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Taken from: Krug II et al., 2015. 
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4. THESIS AIMS 
The endocannabinoid system (ECS) comprises neuromodulatory lipids and 
their receptors, capable of regulating neuronal excitability. It is involved in 
a variety of physiological processes and in specific brain functions, such as 
nociception, control of movement, memory and neuroendocrine regulation. 
Recently, it has also been suggested that the ECS may play an important 
role in early neuronal development, regulating neural progenitor 
proliferation, differentiation and specification. Because of redundancy and 
promiscuity that characterize this system, it becomes indispensable to 
establish roles, functions, and contributions of single genes involved in 
ECS. The vertebrate Danio rerio represents a valid model system to study 
eCB biology, since phylogenetic analyses of the zebrafish ECS have 
demonstrated that it is highly conserved with the mammalian counterpart. 
For this reason the first goal of my PhD thesis was to evaluate the spatial-
temporal expression profiles of different ECS genes during zebrafish 
development. Moreover, since the 2-arachidonoylglycerol (2-AG) is 
synthesized at high levels in CNS by diacylglycerol lipase α (Daglα), the 
second objective was to investigate the role of 2-AG in the development 
and differentiation of neurons, and in the formation of neuronal circuits 
that control spontaneous locomotion and visual system in zebrafish 
embryos. 
Particularly, considering the key role of eCB signalling during 
neurogenesis, we hypothesized that daglα downregulation could affect 
axonal pathfinding during zebrafish embryogenesis, as it has been 
demonstrated in previous studies on cnr1, the CB1 coding gene (Watson et 
al., 2008). In this thesis work, our hypothesis is that the alteration of the 
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function of the 2-AG synthesis enzyme can produce similar effects in terms 
of alterations of the axonal phenotype, revealing as well unexplored 
aspects of the 2-AG during vertebrate neurogenesis.  
Finally, the third purpose of this work was to highlight the role of 2-Ag 
and its main receptors (CB1 and CB2) in the correct differentiation and 
lamination of zebrafish neuroretina, and in the correct formation of 
retinotectal system. Moreover we intended to understand if CB1 and CB2 
receptors could also direct the correct formation of neuronal circuits that 
control spontaneous locomotion during zebrafish embryogenesis. 
In summary, in the present work we aimed to: 
 characterize the spatial-temporal expression profiles of ECS genes 
during zebrafish development by qPCR and in situ hybridization; 
 inhibit the 2-AG synthesis in zebrafish embryos by morpholino-
induced knockdown for Daglα; 
 reveal disorganization of neurons in defined area of the brain by 
acetylated tubulin immunostaining; 
 test the role of 2-AG in swimming behaviour by locomotor assays 
and in visual sensitivity by oculomotor analysis;   
 rescue of the morphant phenotype by administration of a 2-AG 
analog; 
 analyze the role of Daglα, CB1 and CB2 in correct formation of 
neuroretina and retinotectal system by using morpholino and 
pharmacological treatments in zebrafish transgenic lines; 
 test the role of these two receptors also in swimming behaviour by 
locomotor assays. 
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5. RESULTS 
The complexity of how eCB signaling regulates the activity of nerve 
circuits within the central nervous system is further obscured by the fact 
that numerous genes have been identified that provide alternate routes of 
eCBs degradation or synthesis, thereby resulting in region-specific ligand 
signaling profiles (Ahn et al., 2008; Di Marzo, 2011). Moreover, the effects 
of CB receptor signaling depend on specific cell types involved, which 
may be associated with opposing outcomes such as inhibition or excitation 
of a neural circuit. For this reason, it becomes indispensable to establish 
when and where eCB genes are expressed, in order to permit later studies 
of the CB signalling system at any given time in the zebrafish lifespan. 
Therefore, we described the spatial and temporal expression profile of 
different ECS genes during zebrafish development. 
5.1 Temporal expression profile of ECS genes during zebrafish 
development 
Using 17 human endocannabinoid genes as reference, a recent 
bioinformatics analysis identified a well-conserved repertoire of ECS 
genes in the zebrafish genome (McPartland et al., 2007). This finding 
prompted us to profile the expression of different ECS genes at different 
stages of zebrafish embryonic development, in collaboration with the 
Endocannabinoid Research Group, Institute of Biomolecular Chemistry 
(ERG-ICB) in Pozzuoli, Naples, coordinated by Dr Vincenzo Di Marzo. 
We designed a set of primers that target the orthologous genes involved in 
AEA and 2-AG metabolism and in the synthesis of ECS receptors (Table 
5), and we chose 12, 24, 48 (before and after hatching), 72 hpf and 4 dpf as 
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developmental time points. By using quantitative PCR and eef1a1l 
(eukaryotic translation elongation factor 1 alpha 1, like 1) as reference gene, we 
found detectable mRNA expression starting from 12 hpf for all analyzed 
genes, except for cnr1, which was first detectable at 24 hpf (Fig. 15).  
More interestingly, the temporal dynamics of AEA biosynthetic (nape-pld, 
abhd4) and catabolic (faah) enzyme expression significantly increased 
during the developmental period under investigation (Fig. 15A).  
The 2-AG biosynthetic enzyme (daglα) also increased its expression 
during the same time, while, conversely, 2-AG catabolic enzyme genes 
mgll and ptgs2b were down-regulated during the pre-hatching period (24-
48 hpf; Fig. 15B). 
While ECS receptors (cnr1, trpv1, and gpr55) increased their expression in 
a time dependent manner, of note, only marginal cnr2 mRNA expression 
was observed during zebrafish development, with no increase even in later 
larval stages (Fig. 15C). 
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TABLE 5. Quantitative PCR primer pairs used for ECS temporal 
dynamics during zebrafish development 
Primer 5‟-3‟ 
Gene Forward Reverse 
daglα GAGGGTTTCCGTCGTCAC TGTTCCTCCAGCAATGATCC 
mgll AAGTGAAGGTGAGAGGAT AATGTCCAACGATGAAGA 
nape-pld CTCAAGGACATGCACTCA GAGCACAATCTTCAAGACAAT 
abhd4 GCGTCACTCTTATTGAAG TTAGTCCACCGTATTACA 
faah TTTGGATATAAGGGTCATG CTTCTTCAGCACTGTAAC 
ptgs2b ATCCAGGATGAAGTCTACAAT GCTGTTGACGCCATAATC 
cnr1 TACTGGAAGAGGTCAATC AGAGTCAATAGTGAGCAA 
gpr55 AACTGAAGGTGTGGATAC ACGCCATAATGTTTAACG 
trpv1 TTGGATTGACTACAGATAAC AATGGTGAACTTGAACAG 
cnr2 TGGAGAACAAACTGGAACAA GGTCAGCAGGACCAAAATGT 
eef1a1l1 CTTCTCAGGCTGACTGTGC CCGCTAGCATTACCCTCC 
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Figure 15. ECS genes are expressed in zebrafish embryos and larvae at levels 
that increase during development. Quantitative PCR values of each sample 
group were obtained from a pool of 20 whole embryos at different embryonic and 
larval stages. (A-C) ECS genes are arranged in AEA metabolic enzymes (A), 2-
AG metabolic enzymes (although ptgs2b is also involved in AEA catabolism) 
(B), and eCBs receptors (C). Stages 48 hpf with andwithout refer to the chorion 
presence/absence in synchronous embryos. Results are the mean of 3 separate 
experiments. Data and statistical significance are expressed relative to the 12 hpf 
group. Relative expression ± SEM as determined by Bio-Rad CFX Manager 
software. *P , 0.05; **P , 0.01.  
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5.2 Analysis of endocannabinoid levels during zebrafish embryonic 
and larval developmental stages 
Having found expression of a complete ECS genetic system during the 
different developmental stages analyzed in collaboration with ERG, we 
next investigated the presence of eCBs and their congeners at different 
time points by means of liquid chromatography-mass spectrometry 
analyses on pre-purified lipid extracts. Of interest, 2-AG was found to be 
the most abundant eCB in the zebrafish developing embryos, and its levels 
followed a profile that closely resembled that of daglα mRNA transcript 
levels (Figs. 15B and 16A). Of importance, unfertilized eggs instead 
displayed higher contents of eCBs, such as 2-AG, palmitoylethanolamide 
(PEA) and oleoylethanolamide (OEA) compared with embryos at 12 hpf, 
which suggested a possible maternal source required for egg fertilization 
(Fig. 16 A, C). Temporal dynamics during embryonic development toward 
hatching showed increasing levels of 2-AG, whereas AEA, PEA, and OEA 
levels did not change appreciably (Fig. 16). With the exception of PEA, 
levels of all compounds tended to decrease in hatched embryos (comparing 
48 hpf embryos with and without chorion), although this effect was 
statistically significant only for 2-AG, which indicated that a significant 
amount of this eCB was retained in the chorion. An increase, which was 
statistically significant only for PEA and 2-AG, was again noted at early 
larval stage (72 hpf; Fig. 16 A, C). 
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Figure 16: eCB levels during zebrafish development. 2-AG levels are higher in 
unfertilized zebrafish eggs, embryos, and larvae compared with AEA and related 
mediators during development (A-D). Liquid chromatography-mass spectrometry 
quantification of the main eCBs and N-acylethanolamines: 2-AG (A), AEA (B), 
PEA (C), and OEA (D). Each sample was obtained from a pool of 50 unfertilized 
eggs, embryos (12, 24, and 48 hpf), or larvae (72 hpf). Stages 48 hpf with and 48 
hpf w/o refer to the chorion presence/absence in synchronous embryos. Data are 
expressed as means ± SD of 3 independent experiments. *P , 0.05; **P , 0.01.   
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5.3 Dagls and Magl enzymatic activities reflect increased 2-AG 
turnover during embryonic development 
Since 2-AG appears to be the most abundant eCB during zebrafish 
development, we proceeded, in collaboration  with Di Marzo‟s group, to 
evaluate the endogenous enzymatic activities involved in its metabolism. 
By using radiolabeled substrates we were able to extrapolate the enzymatic 
rate for different developmental time points. Both Dagls and Magl 
activities showed an increased trend with time (Fig. 17), although Dagls 
increase starts to be significant from 48 hpf. The absolute activity of these 
anabolic enzymes was consistently higher than Magl for all developmental 
time points and corresponds with the daglα expression pattern (Fig. 15).  
 
Figure 17: Enzymatic activities of biosynthetic (DAGLs) and catabolic 
(MAGL) 2-AG enzymes. Each sample was obtained from a pool of 50 embryos 
or larvae. Data are expressed in pmol/min/mg of protein and as means ± SD of 3 
independent experiments. Statistical significance is given with respect to the 
12 hpf group. P , 0.05; **P , 0.01. 
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5.4 Spatial-temporal characterization of ECS gene expression profiles 
The establishment of endocannabinoid signalling requires the temporal and 
spatial coincidence of metabolic enzyme and receptor expression during 
brain development. 
Despite efforts directed toward understanding endocannabinoid signaling 
in the postnatal brain, a surprising lack of data exists with regard to 
detailed developmental studies on the distribution of sn-1 diacylglycerol 
lipases (Dagls), the prime 2-arachydonoylglycerol (2-AG) synthetic 
enzymes, monoacylglycerol lipases (Magl), the 2-AG hydrolyzing enzyme, 
and the by far well known cannabinoid receptors during brain 
development. 
Therefore, in order to better understand and define the basic developmental 
and signaling principles controlled by eCBs, we identified possible sites of 
action for eCB signaling in zebrafish neurogenesis, analyzing the 
expression patterns of several ECS genes at different developmental stages: 
24, 48 and 72 hpf via whole mount in situ hybridization (WISH).  
In this way, we confirmed data already available in the literature, such as 
those for daglα and cnr1 (Lam et al., 2006; Watson et al., 2008), and 
identified new ones, not yet present in literature, as in the case of 
transcriptional profiles of daglβ, mgll, and trpv1, as well as of daglα at 24 
and 72 hpf. As for expression profiles of cnr2 and gpr55 receptors, we 
were not able to detect specific staining patterns at any of the zebrafish 
developmental stages analyzed.  
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5.5 Spatial-temporal characterization of 2-AG metabolic enzymes 
expression profiles 
Since 2-AG seems to be the most abundant eCB during zebrafish 
development, we proceeded, to evaluate the expression profiles of its 
metabolic enzymes during different zebrafish developmental stages. 
First, we analyzed the expression patterns of daglα and, for the first time, 
daglβ, the paralogous genes that encode for the major synthesizing 
enzymes for 2-AG. 
At prim5 stage (24 hpf) it is possible to observe that the expression profile 
of daglα is localized in the dorsal telencephalon (olfactory placode), 
ventral hypothalamus, tegmentum, hindbrain and spinal cord. By the long 
pec stage (48 hpf), as reported by Watson and collaborators (Watson et al., 
2008), the transcript was still expressed in the telencephalon, 
hypothalamus, tegmentum, and hindbrain, and it appeared in midbrain and 
cranial ganglia, thus showing widespread distribution in all major 
compartments of the brain and in the ganglion layer of the retina (Fig. 18 
A-C, G). This expression profile remained unchanged at 72 hpf. 
daglβ exhibited an expression profile spatially and temporally similar to 
that of its paralogue daglα in telencephalon, hypothalamus, midbrain, 
hindbrain, spinal cord, and retinal ganglion layer, but with slightly broader 
expression levels (Fig. 18 D, E, F, H) from 24 to 72 hpf.  
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Figure 18: daglα and daglβ gene expression profiles during zebrafish 
neurogenesis. Whole-mount in situ hybridization analysis shows the expression 
of daglα in telencephalon, hypothalamus, hindbrain, and spinal cord at the stage 
of 24 hpf (A). At 48 hpf, mRNA labeling is restricted to the central nervous 
system with a widespread distribution in all major brain compartments (B, C) and 
in the ganglion cell layer of the retina (G). daglβ shows a very similar expression 
profile, including telencephalon, hypothalamus, hindbrain, and spinal cord from 
24 to 72 hpf but slightly more diffuse (D, E, F, H). (A, B, D, E) Anterior to left 
and (C, F) to top. (A, B, D, E) Lateral and (C, F) dorsal views. (G, H) Several 
focal plans were combined lateral views of explanted eyes. Abbreviations: Te, 
telencephalon, HB, hindbrain; Hy, hypothalamus; PD, pronephric duct; RGC, 
retinal ganglion cells. 
 
Next, we analyzed for the first time, by WISH, the expression pattern of 
mgll, the gene that encodes for the major catabolic enzyme for 2-AG. At 
the blastula stage and throughout epiboly, maternal, and zygotic stages, 
mgll transcripts were ubiquitously distributed (Fig. 19 A-C). During early 
somitogenesis, mgll expression became restricted to a single domain in the 
rostral brain that encompasses telencephalon, diencephalon, and 
tegmentum (Fig. 19 D, E), and to a region of the pronephric ducts 
encompassing the proximal straight and distal early segments (Fig. 19 F).  
By late somitogenesis (22 hpf) and early post-somitogenesis (25 hpf), mgll 
mRNA was clearly visible in neuronal clusters associated with the dorsal 
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pallium, preoptic area, and epiphysis, and more weakly in tegmentum (Fig. 
19 G-J).  
The signal in the pronephric ducts was restricted to one somite length of 
tubule epithelium in the distal early segment (25 hpf; Fig. 19 L). As 
development proceeds, mgll expression remained in the telencephalon, 
anterior hypothalamus, and epiphysis (Fig. 19 M, N), whereas additional 
mgll mRNA signals became progressively discernable. At 28 hpf, 
transcript expression was extended to distinct neuronal clusters that 
stretched dorsally in the molecular layer of the cerebellar primordium or 
that were located latero-ventrally in each rhombomere (Fig. 19 M, O). At 
48 hpf, instead, expression was detected also in the optic tectum, pectoral 
fin mesenchyme, and in a region of the eye that seems to include the retinal 
ganglion cell layer as suggested by co-localization of mgll and fgf8a 
transcripts – the latter being a marker of retinal ganglion cells (Fig. 19 P, 
Q) – and later at 72 hpf mgll the signal was restricted to the ventricular 
zone. 
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Figure 19: Dynamic expression of mgll during zebrafish neurogenesis. WISH 
shows maternal contribution (A) and ubiquitous expression during gastrulation 
(B, C). During somitogenesis (14 hpf), mgll mRNA is seen in a rostral domain, 
including telencephalon, diencephalon, and tegmentum (D, E), and in a large 
segment of the pronephric ducts (F). During late somitogenesis (22 and 25 hpf), 
mgll expression is found in neuronal clusters located in dorsal pallium, preoptic 
area, epiphysis (*), and tegmentum (G-J). Expression in the tubular epithelium of 
the pronephros is seen in lateral view (K) and in section through the trunk (L). 
Additional expression becomes progressively discernable in the cerebellum, 
hindbrain (M, N), optic tectum (P), pectoral fins (P), and eye (Q). Inset in panel Q 
highlights co-expression of fgf8a, a marker of retinal ganglion cells, and mgll as 
shown by signal merging (arrowheads). At 72 hpf mgll is expressed in the 
ventricular zone (R). Different focal planes were combined in O. Animal pole and 
dorsal view in A and O, respectively; lateral view in B and C; anterior to the left 
and lateral view in D, F, G, I, J, M, P and R; anterior view in E, H, K, and N. Ce, 
cerebellum; HB, hindbrain; Hy, hypothalamus; OT, optic tectum; PD, pronephric 
duct; PF, pectoral fin; PO, preoptic area; RGC, retinal ganglion cell layer; Rh, 
rhomboencephalon; Te, telencephalon; Tg, tegmentum, vz, ventricular zone. 
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5.6 Spatial-temporal characterization of 2-AG main receptor 
expression profiles 
After analyzing the expression profiles of the principal genes involved in 
synthesis and degradation of 2-AG, we investigated the expression 
territories of its major receptors. Even if we were able to isolate and clone 
various transcripts coding for the main 2-AG receptors, only WISH 
experiments for cnr1 and trpv1 mRNAs generated a good signal, while no 
or very weak signal was detected for cnr2 and gpr55 transcripts, maybe 
due to low RNA abundance. 
Largely in agreement with previous studies (Lam et al., 2006; Watson et 
al., 2008), we found that cnr1 gene was expressed by the prim 5 stage, 24 
hpf, in the preoptic area, hypothalamus, dorsal telencephalon, ventral 
thalamus, ventral tegmentum, and posterior hindbrain (Fig. 20 A, B). As 
development proceeds, its expression extended also to other neuronal 
populations. Thus, by the long pec stage, 48 hpf, cnr1 was expressed in the 
telencephalon, preoptic area, hypothalamus, ventral thalamus, and ventral 
tegmentum. mRNA was also distributed in midbrain and hindbrain though 
more weakly (Fig. 20 C, D). At 72 hpf, the signal persisted in the above 
regions, and appeared also in the dorsal thalamus, optic tectum, and 
cerebellum. 
Comparing the expression patterns of cnr1, daglα, daglβ and mgll, it seems 
that these genes are tightly co-regulated in specific areas of the 
telencephalon, hypothalamus, midbrain, and hindbrain (Fig. 20 F). 
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Figure 20: cnr1 gene expression profile during zebrafish neurogenesis. 
Whole-mount in situ hybridization analysis shows the expression of cnr1 in 
telencephalon, preoptic area, ventral thalamus, ventral tegmentum and caudal 
hindbrain at 24 hpf (A–B). At 48 hpf, expression was seen in telencephalon, 
preoptic area, hypothalamus, thalamus, and tegmentum (C–D). At 72 hpf, the 
transcript is widely distributed in all major compartments of the brain (E). The 
images were acquired in lateral (A, C, E) and dorsal (B, D) view. Abbreviations: 
Te, telencephalon; PO, preoptic area; th, thalamus; Tg, tegmentum; Rh, 
rhombencephalon; Hyp, hypothalamus; Di, diencephalon; Mb, midbrain; TO, 
optic tectum. 
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Since recent studies have demonstrated that intact 2-arachidonoylglycerol 
is an endogenous Trpv1 activator that contributes to phospholipase C-
dependent Trpv1 channel activation and Trpv1-mediated anti-nociceptive 
signalling in the brain (Zygmunt et al., 2013; Petrosino et al., 2016), we 
lastly analyzed for the first time trpv1 gene expression. 
At prim5 stage (24 hpf) it was possible to observe that the expression 
profile of zebrafish trpv1 was localized in few neural and sensory cell 
types within sensory cranial ganglia flanking the hindbrain, and in the 
Rohon–Beard cells localized in the dorsal aspect of spinal cord (Fig. 21 A).  
At long pec stage (48 hpf), and protruding mouth stage (72 hpf), trpv1-
positive cells were similarly distributed as they were seen in two columns 
projecting toward the eye in the ventral head mesenchyme, and in 
trigeminal sensory neuron subtypes (Fig. 21 B-E). Cells expressing trpv1 
also were found at the base of the pectoral fins, suggesting a 
correspondence to pectoral motor nerve ganglia (Fig. 21 B-E). No spinal 
cord labelling was detected at this stage.   
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Figure 21: Few neural and sensory cell types expressing trpv1: Whole-mount 
RNA in situ hybridization of trpv1 from 24 to 72 hpf. Embryos are oriented with 
head toward the left in lateral views (A, B, D) and head toward the left in dorsal 
views (C, E). (A) trpv1 mRNA in cranial ganglia (cg) and Rohon-Beard (rb) 
neurons at 24 hpf. (B-E) Expression in trigeminal (white arrowhead), cranial 
(arrow) and pectoral (black arrowhead) neurons at 48 and 72 hpf. 
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5.7 daglα down-regulation to decrease 2-AG levels  
From mass spectrometry analysis that was performed in collaboration with 
Dr. Di Marzo (ERG, ICB-CNR, Pozzuoli, Naples), we found that 2-AG 
levels were elevated and actively produced during zebrafish embryogenesis 
(Fig. 16). 
To ascertain its function during development, we knocked down the 2-AG 
biosynthetic enzyme daglα in order to decrease 2-AG levels in embryos 
and larvae by using morpholino (MO), an antisense oligonucleotide that 
inhibits translation by "steric blocking", binding to a specific target 
sequence within an RNA. Considering the key role of EC signalling during 
neurogenesis, we hypothesized that MO-induced down-regulation of dagla 
would impair axonal pathfinding during zebrafish embryogenesis as it has 
been shown in cnr1 knockdown experiments (Watson et al., 2008).  
We used two different antisense MOs for this gene, one directed against 
the translational start site of the coding sequence (daglα-Tb1) and the other 
targeting the exon 3 – intron 3 splice site boundary (daglα-Sb1). 
As control, in order to increase the 2-AG levels, we knocked down the 2-
AG catabolic enzyme mgll, using also in this case two different antisense 
MOs: one directed against the translational start site of the coding sequence 
(mgll-Tb1) and the other targeting the exon 2 – intron 2 splice site 
boundary (mgll-Sb1). The binding sites of the different MOs are 
schematized in Fig. 22. 
Dose-response relationships were investigated to assess toxicity and 
determine the working concentration of MOs (Fig. 23). 
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Figure 22: Representation of oligo-Morpholino binding sites. A) At the top, 
the physical map of the daglα gene is illustrated with the corresponding domains 
represented in different colors. It is highlighted the region comprising the binding 
sites of morpholino daglα-Tb1 (green line), ATG translation site starting site; 
daglα-Sb1 (blue line), between the exon3-introne3 (ATACGCCTAG-gtaagacgta) 
junction. This last is also represented in red in the corresponding amino acid 
sequence of the gene (A'). B) Below it is represented the physical map of the mgll 
gene. Morpholino mgll-Tb1 (green line) binds to the ATG translation start site; 
morpholine mgll-Sb1 (blue line) between the exon 2-intron 2 (GTCCTCCGAA-
gtaagtgtga). 
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Figure 23: Dose-response relationship of oligo-morpholino. Statistical analysis 
of mortality induced by control, daglα (A) and mgll (B) morpholinos at different 
concentrations (300, 600 and 900 μM) and at different stages of zebrafish 
development (24, 48 and 72 hpf) to define the optimal working concentration 
(300 μM) with the highest survival rate (alive). 
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Zebrafish 1-cell stage embryos were injected with either MO, then sampled 
at different developmental stages for 2-AG level measurement. In line with 
the biochemical function of Daglα, MO-based knockdown produced a 
significant reduction in endogenous 2-AG after microinjection of either 
daglα-Tb1 or daglα-Sb1 MOs compared with uninjected embryos or vs. 
those injected with control MO (Fig. 24 A).  
These data are in agreement with the notion that Daglα is the major 2-AG 
biosynthetic enzyme. Of interest, on the other hand, we found a significant 
increase of 2-AG levels in mgll-Tb1 and mgll-Sb1 MO-injected embryos, 
also here in line with the catabolic function of this enzyme (Fig. 24 B).  
 
 
 
Figure 24: Analysis of 2-AG levels in daglα and mgll morphants. 
Quantification of 2-AG by liquid chromatography-mass spectrometry in fish at 48 
and 72 hpf shows a significant reduction in daglα-Tb1 and daglα-Sb1-MO 
injected embryos (A) and a significant increase in mgll-Tb1 mgll-Sb1 MO-
injected embryos (B). Standard control MO (scMO) indicates the values in 
corresponding synchronous stages, which did not differ significantly from each 
other. Data obtained in collaboration with Dr. Di Marzo‟s research group (ERG, 
ICB-CNR, Pozzuoli, Naples). 
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Finally, to confirm that the morphologic abnormalities as well as the 
changes in 2-AG levels were specific effects of MO injections, we decided 
to analyze daglα and mgll transcripts by RT-PCR. These analyses clearly 
showed that both MOs for the splicing site induced a premature stop codon 
in daglα and mgll mRNA. Specifically, cDNA sequencing revealed a 
partial exon 3 skipping and partial intron 2 retention generating premature 
stop codons in daglα and mgll mRNAs, respectively (Fig. 25). 
 
Figure 25: RT-PCR analysis of embryos injected with daglα-Sb1 and mgll-
Sb1 morpholinos. From the agarose gel electrophoretic analysis, compared to the 
control (scMO), it is possible to see a lower band due to the 23 bp deletion in 
exon 3 of the daglα transcript (A), resulting in alteration of the reading frame and 
formation of a premature stop codon (highlighted in red), confirmed by 
sequencing analysis (A'). On the contrary, there is a higher band due to the 84 bp 
insertion in the intron 2 of mgll transcript (B), leading also in this case an 
alteration of the reading frame and formation of a premature stop codon 
(highlighted in red), also confirmed by sequencing analysis (B').   
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5.8  Role of Daglα in axon growth 
Whereas both ATG and splice site targeted MOs seemed to perturb 2-AG 
levels and axon formation in a similar manner (60–80% of larvae analyzed 
showed defects in axon growth), thereby implying a link between daglα 
down-regulation and neuronal phenotype, only results obtained with daglα-
Tb1 MO are presented here. To minimize the potential for confounding 
results from morphological abnormalities (daglα morphant larvae that 
showed severe defects in body morphology had defective axon growth), we 
analyzed only those MO-microinjected larvae at 3 dpf that were not 
disturbed in their overall morphology (70%), but, however, appeared 
darker in pigmentation pattern (Fig. 26).  
 
 
 
Figure 26: Body morphology of daglα-Tb1 injected fish. Compared to the 
control, in 70% of cases, daglα-Tb1 MO or mgll-Tb1 MO-injected fish did not 
show significant abnormalities in the structure of the body, neither the curvature 
of the tail, nor even cardiac edema. 
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Analysis of daglα-Tb1 MO-microinjected larvae stained with an antibody 
against acetylated α-tubulin (component of the neuronal microtubules, 
marker of the structural function of the axon) revealed abnormalities in 
disparate fiber tracts in specific brain regions.  
Previous studies reported that the majority of neuron cell bodies of the 
optic tectum are located in the superficial periventricular layer, which 
contains the main tectal neuropil (TNP) and axons of the superficial 
neuropil layer (SNL) just under the epidermis (Robles et al., 2011). A 
comparison with controls illustrated that: 
- the number of SNL axons was significantly reduced in 71% of 
dagla morphant larvae, with fewer or no axons reaching the dorsal 
midline from the TNP (Fig. 27 A, B, M);  
- in support of the correlation between ECS and axon growth, 
analysis of the cerebellum underscored the abnormal axonal 
patterning of knockdown larvae. The projection pattern of nerve 
fibers in the rhombic lip of the cerebellum revealed a statistically 
significant difference between groups. Indeed, cerebellar fibers 
from both halves stopped their elongation prematurely and were not 
properly extended toward the dorsal midline in 80% of daglα 
knockdown larvae (Fig. 27 D, E, N); 
- investigating also the retinal ganglion cell axons in the optic nerves 
and tracts, 61% of dagla morphants displayed hypoplastic optic 
nerves, which appeared restricted rostrocaudally relative to the 
control region (Fig. 27 G, H); 
- furthermore, anterior vagal nerves were disorganized, with 
misrouted or extra axons in 60% morphant larvae (Fig. 27 J, K).  
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To gain further evidence that impaired axonal outgrowth is really the 
consequence of daglα knockdown and subsequent reduction of 2-AG 
levels – Daglα enzyme also produces other 2-acylglycerols with little or no 
action at CB1 receptors – we treated Daglα-deficient embryos from 70% 
epiboly until 72 hpf with the CB1 cannabinoid receptor agonist and non-
hydrolysable 2-AG analog, noladin ether (2-Arachidonylglycerylether) 
(Hanuš et al., 2001). Of interest, we found that the axonal phenotype of 
noladin ether administered daglα morphants did show a partial rescue of 
SNL axon loss, and nerve elongation defects in the molecular layer of the 
cerebellum (Fig. 27 C, F, I, L, M, N). These results suggest that primary 
axon tract formation in Daglα-depleted zebrafish is impaired as a result of 
decreased 2-AG levels. We subsequently decided to investigate functional 
traits of daglα morphant larvae in terms of vision and locomotion. 
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Figure 27: Loss of Daglα causes specific defects in axonal outgrowth. A–L) 
daglα-Tb1 MO-injected larvae (72 hpf) are characterized by substantial reduction 
of SNL axons (black arrowheads) (A–C), limited extension of cerebellar nerves 
(double arrows) (D–F), reduced thickness of the optic nerves (square brackets) 
(G–I), and abnormal branches in the anterior facial motor neurons (white arrow) 
(J–L). Axonal defects are less severe in daglα-Tb1 MO-injected larvae that were 
treated with noladin ether, a stable 2-AG analog. M, N) Statistical analysis 
showing a substantial reduction in the number of SNL axons (M) and the distance 
between cerebellar axons across the midline in daglα morphant larvae (N). M) 
Treatment of knockdown larvae with noladin ether causes significant rescue of 
SNL axons in a dose-dependent manner. Scattered dots at the same level are 
individual larvae with the same number of axons. Molar concentration refers to 
the concentration of noladin ether. Statistical analysis was performed by using 
Kruskal-Wallis test followed by Dunn‟s multiple comparison test. Scatter plots 
represent means ± SEM of 3 independent experiments (n = 180). Anterior to the 
top. Dorsal views in A–F; ventral views in G–L. Ce, cerebellum; L, lens; ON, 
optic nerve; RGC, retinal ganglion cell axon; scMO, standard control MO; x, 
vagal sensory nerve. **P , 0.01; ***P , 0.001. 
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5.9 Vision acuity and sensitivity in Daglα-deprived larvae 
A functional ECS is thought to be required in the developing visual system 
to shape retinal responses to light and in visual processing (Ryskamp et al., 
2014; Keimpema et al., 2010; Cécyre et al., 2013).  
Investigations into the visual system development and functions necessitate 
quantifiable behavioral models of visual performance that are easy to elicit, 
and that are robust and simple to manipulate. A suitable model has been 
found in the optokinetic response (OKR), a reflexive behavior present in 
all vertebrates due to its high selection value. The OKR is a stereotyped 
eye movement in response to movement in the surround and involves slow 
stimulus-following movements of eyes alternated with rapid resetting 
saccades. This serves to stabilize the visual image on the retina, and allows 
for high-resolution vision. In the laboratory, OKR is usually elicited using 
a black-and-white striped drum that ideally revolves around the subject. 
The resulting slow eye movements following the drum rotation (slow 
phase) are interrupted by fast resets in opposite direction (fast phase), 
referred to as optokinetic nystagmus (OKN). Eye movements are recorded 
and automatically analyzed in real time. Data analysis enables immediate 
recognition of parameters such as slow and fast phase duration, movement 
cycle frequency, slow-phase gain, visual acuity, and contrast sensitivity 
(Fig. 28). The measurement of this behavior is easily carried out in 
zebrafish larvae, due to its early and stable onset (fully developed after 96 
hpf). OKR can be used as a screening assay, enabling the analysis of 
sensory-motor control and visual system performance in great detail 
(Huang and Neuhauss, 2008; Mueller et al., 2011). 
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The hypothesized role of ECS in vision, together with the axonal growth 
deficits that we detected here in zebrafish daglα morphants, prompted us to 
test whether optokinetic performance was altered in Daglα-deficient larvae. 
In collaboration with Prof. Stephan Neuhauss at the Institute of Molecular 
Life Sciences, University of Zurich, Switzerland, we determined visual 
acuity and contrast sensitivity in daglα-Tb1 MO injected embryos, by 
measuring larval OKR, which is the stereotyped eye movement in response 
to movements in the field of vision (Haug et al., 2010). Perturbation of 
optokinetic behavior, which is regulated by the optical and neuronal 
properties of the visual system, could be a result of defects in sensory 
inputs or motor outputs. In OKR experiments, we examined contrast 
sensitivity (Fig. 29 A), spatial sensitivity (Fig. 29 B), and temporal 
sensitivity (Fig. 29 C), and in all cases we observed significantly reduced 
eye velocity (repeated measurement ANOVA P, 0.005), which suggested 
that the visual system is not intact in daglα morphants and that 2-AG 
production is required for proper detection of motion stimuli. 
On the other hand, we did not find any significant alteration of eye velocity 
in mgll-Tb1 MO injected embryos in terms of contrast (Fig. 30 A), spatial 
(Fig. 30 B), and temporal sensitivity (Fig. 30 C), indicating that an increase 
in 2-AG amount could not compromise visual acuity and optokinetic 
behavior. 
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Figure 28: Schematic drawing of the setup used to stimulate and record 
optokinetic responses. Immobilized zebrafish larvae are stimulated with gratings 
projected onto a cylindrical screen. Projection is focused through two convex 
lenses (L1, L2). Intensity is adjusted by optical density filters (OD). Eye 
movements are recorded with a CCD camera and evaluated in real-time in terms 
of eye angle and velocity. Taken from Rinner et al., 2005. 
 
 
 
Figure 29: OKR is reduced in Daglα-deficient larvae. OKR was recorded in 5 
dpf larvae injected with standard control MO (scMO) (blue) and daglα-Tb1 MO 
(green) in response to different contrast (A control n = 17; daglα MO, n = 15); 
spatial frequency (B control, n = 17; daglα MO, n = 17) and angular velocity (C 
control, n = 18; daglα MO, n = 18). In all cases, we observed significantly 
reduced eye velocity. scMO, standard control MO; Data are shown as means ± 
SD of 3 independent experiments (repeated measures ANOVA P , 0.005). 
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Figure 30: OKR is not compromised in Mgll-deficient larvae. OKR was 
recorded in 5 dpf larvae injected with standard control MO (scMO) (blue), mgll-
Tb1 MO (green) and uninjected larvae (beige) in response to different contrast (A 
control n = 17; mgll MO, n = 15); spatial frequency (B control, n = 17; mgll MO, 
n = 17) and angular velocity (C control, n = 18; mgll MO, n = 18). In all cases, we 
did not observe any significant alteration of eye velocity. scMO, standard control 
MO. 
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5.10  Locomotor phenotype caused by Daglα depletion 
It is well-known that eCBs play an important role in the activation and 
modulation of the motor system (El Manira and Kyriakatos, 2010). 
Zebrafish larvae are highly motile and display a variety of stereotypical 
movement behaviors, including cyclic swimming and fast-startle responses 
(Brustein et al., 2003).  
To characterize the role of 2-AG with respect to the spontaneous motor 
activity of zebrafish larvae, we examined the swimming behavior in Mgll 
and Daglα-deficient embryos at 72 hpf by using DanioVision (Noldus) 
technology. Mgll-depleted embryos featured mild locomotor hyperactivity, 
showing an increase of distance moved and speed (Fig. 31). Differently 
from mgll-MO, we found that Daglα-depleted embryos had a lower mean 
velocity and moved less compared with control embryos during the 
observation period, both in terms of distance moved and velocity (Fig. 31). 
Therefore, these data lend support to the hypothesis that 2-AG is needed 
for the proper function of the locomotor system. We concomitantly treated 
Daglα-deficient embryos with different concentrations of noladin ether 
from 70% epiboly stage until 72 hpf. Of interest, although the rescue effect 
was statistically significant for the distance moved, mean velocity 
reduction was only partially mitigated in treated daglα morphant embryos 
(Fig. 32). 
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Figure 31: Locomotor phenotype in Daglα and Mgll-deficient larvae. daglα 
morphants have impaired spontaneous movement compared with standard control 
MO (scMO) – injected larvae, instead Mgll-depleted embryos featured mild 
locomotor hyperactivity. This was quantitatively assessed by using Ethovision XT 
software analysis. Distance moved and mean velocity graphs obtained from 3 
independent experiments. Statistical analysis was performed by using Kruskal-
Wallis test followed by Dunn‟s multiple comparison test. Bars represent mean ± 
SEM. *P , 0.05; ****P , 0.0001. 
 
 
 
Figure 32: Locomotion is impaired in Daglα-deficient larvae. Motion-tracking 
plots suggest that daglα morphants have impaired spontaneous movement 
compared with standard control MO (scMO)–injected larvae, and that this 
locomotor phenotype was, at least in part, ameliorated by treatment with CB1-
specific agonist noladin (A). This was quantitatively assessed by using Ethovision 
XT software analysis. Mean distance moved (B) and mean velocity (C) graphs 
obtained from 4 independent experiments. Statistical analysis was performed by 
using Kruskal-Wallis test followed by Dunn‟s multiple comparison test. Bars 
represent mean ± SEM. *P , 0.05; ****P , 0.0001. 
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5.11 Locomotor phenotype caused by cannabinoid receptors 
antagonists 
To address the question if the reduction of 2-AG levels could induce 
locomotor alterations via CB1 and/or CB2, spontaneous locomotion 
analysis was conducted on larvae treated with cannabinoid receptors 
antagonists. These are a type of cannabinoidergic drugs that bind to 
cannabinoid receptors and prevent their activation by endocannabinoids. 
They include antagonists, inverse agonists, and antibodies of CBRs. 
In this study, we used two different inverse agonists for CB1, AM251 and 
SR141716 (also known as Rimonabant), which are structurally very 
similar, and one inverse agonist for CB2, AM630. Their structures are 
illustrated in Fig. 33. 
 
 
 
Figure 33: Molecular structure of cannabinoid receptors antagonists. AM-
251 and SR141716 are inverse agonists for CB1 receptor, while AM-630 is an 
inverse agonist for CB2 receptor. 
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Zebrafish embryos were exposed to CB1/CB2 antagonists at different 
concentrations (0,5-1-2,5-5 μM) from 70% epiboly (~7 hpf), corresponding 
to the end of gastrulation, when the neural plate border gene markers are 
already expressed but neurulation has not yet begun, until 5 dpf.  
Treatments were daily renewed with fresh solution, and embryos were 
evaluated on the basis of standard parameters. Embryos exposed to highest 
drug concentrations (2,5 and 5 μM) did not show any sign of toxicity until 
72 hpf. Moreover, at 5 dpf, the highest doses of AM-251 and SR141716 
induced a slight pericardic edema and alteration of branchial arches, but 
not brain necrosis, hemorrhages and bent spine (Fig. 34). Mortality reached 
the value of 100% at 5 dpf with highest drug concentrations (10 μM for 
AM-251 and AM-630, and 5μM for SR141716). 
 
 
Figure 34: Phenotypic characterization of treated animals. Pharmacological 
treatment with cannabinoid receptors antagonists did not manifest developmental 
abnormalities at 72 hpf, while treatments with maximum concentration of CB1 
antagonists caused pericardic edema and branchial arches alteration in 5 dpf 
larvae. 
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Free-swimming ability of treated animals was compared to vehicle controls 
at 72 hpf and 5 dpf by using DanioVision (Fig. 35-36). Row data were 
analyzed by EthoVision XT software, showing that animals treated with 
CB1 antagonists had a significant reduction in motility, even at lower 
concentrations, both in terms of distance and velocity. At higher 
concentrations, this behavioral phenotype was drastically more severe (Fig. 
35 and 36).  
On the other hand, 5 dpf larvae treated with CB2 antagonist showed a 
lower mean velocity and moved less compared to the control larvae during 
the observation period only when exposed to higher concentrations (2,5 
and 5 μM) (Fig. 36). 
Collectively, these data suggest that CB1 and CB2 receptors are needed for 
the proper function of the locomotor system. Of interest, since we found 
that 2-AG reduction is responsible for motility alterations, we hypothesize 
that this neuromodulator plays an important role in motor control via CB1 
and CB2 activation. 
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Figure 35: Locomotion is impaired in pharmacological treated larvae at 72 
hpf. Treated larvae had impaired spontaneous movements compared with control 
in term of distance (A) and velocity (B). This phenotype was quantitatively 
assessed by using Ethovision XT software analysis. Data are shown as means ± 
SEM of 3 independent experiments; *P  < 0.05; ***P  < 0.0001. 
A 
B 
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Figure 36: Locomotion is impaired in pharmacological treated larvae at 5 
dpf. Treated larvae had impaired spontaneous movements compared with control 
in term of distance moved (A) and velocity (B). This phenotype was 
quantitatively assessed by using Ethovision XT software analysis. Data are shown 
as means ± SEM of 3 independent experiments; *P < 0.05; **P < 0.01; ***P < 
0.0001. 
A 
B 
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5.12  The role of ECS in retinotectal axon guidance  
Since malformations of the optic nerve lead to reduced vision or even 
blindness, the axonal outgrowth deficits that we detected in zebrafish daglα 
morphants, together with the alterations in optokinetic performance, 
prompted us to test whether the ECS could have a role in the correct 
orientation of axons in the developing retino-tectal system. This system 
consists of a variety of cell types, and retinal ganglion cells (RGCs) are an 
excellent model system to tackle the above question. Restricted to a layer 
adjacent to the inner basement membrane, RGCs show typical neuronal 
polarity, with basally oriented axons and apically oriented dendritic trees. 
RGCs, whose cell bodies are located in the ganglion cell layer (GCL), send 
axons via the optic nerve that relay information outside of the retina, to the 
optic tectum in non-mammalian vertebrates and to the superior colliculus 
(SC) in mammals. The journey of elongating RGC axons is complex. As 
RGCs differentiate, their axons navigate to the optic disc (optic nerve 
head), fasciculate and exit the eye as the optic nerve (Oster et al., 2004; 
Bao et al., 2008). After leaving the eye, axons navigate to the ventral 
diencephalon midline where they form the optic chiasm in the preoptic area 
(POA) with axons from the contralateral eye by crossing to the 
contralateral optic tract on their way to the tectum/SC. In animals with 
monocular vision such as zebrafish, all RGC axons cross the midline 
(Petros et al., 2008). Innervation of the tectum/SC forms a retinotopic 
map, such that axons from cells located adjacently in the GCL project to 
adjacent locations in the tectum/SC (Oster et al., 2004; Reese, 2011). 
Transgenic animals expressing reporter genes in specific classes of 
neuronal cells are powerful tools for the study of gene expression dynamics 
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and neuronal network formation. In zebrafish, through the use of a 
transgene that drive fluorescent proteins under the control of an enhancer-
promoter from the ath5 gene (atoh7), it is possible to analyze the 
differentiation of RGCs from their final mitosis at the apical surface, 
through the initiation of their axonal and dendritic processes (Poggi et al., 
2005). Thus, for this study, we used the zebrafish transgenic line 
Tg(pBatoh7:gap43-gfp)
cb1
 ('ath5:gap-gfp') generated in the laboratory of 
Prof. William A. Harris at the Department of Physiology, Development 
and Neuroscience, University of Cambridge (UK). This transgenic line, 
that express a fluorescent protein [enhanced green fluorescent protein 
(EGFP)] fused to the GAP43 N-terminal palmitoylation signal under the 
control of the zebrafish ath5 promoter (Zolessi et al., 2006), allowed us to 
examine the consequences of genetic and pharmacological manipulations, 
thus providing an immediate read-out of RGC-specific behaviours. In 
zebrafish, RGCs begin to differentiate around 28 hpf, then axons exit the 
eye around 32 hpf, cross the chiasm at 34-36 hpf and fully innervate the 
tectum at 72 hpf. 
We analyzed the zebrafish 'ath5:gap-gfp' larvae at 5 dpf when the RGC are 
completely formed, finding that dagla-Tb1 MO-microinjected larvae, in 
65% of cases, showed an abnormal optic nerve development, whose axons 
appeared to project abnormally and to stray from the optic nerve before 
reaching the optic tectum (Fig. 37). Moreover, we compared the size of the 
tectal neuropil observing that, in 65% of cases, it was ~50% smaller on 
average in morphants than in their control counterparts (Fig. 38). Also, 
axonal projections abnormally projecting outside the optic tectum area 
were observed in 35% of cases. 
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Figure 37: Daglα-depleted embryos show aberrant RGC projections at 5 dpf. 
Compared to controls injected with standard control MO (scMO) (A), knock-
down of daglα causes guidance defects of RGC axons (white arrows), that stray 
from the optic nerve in 65% of cases (B-C) and project far from the optic tecum 
area in 35% of cases (D). 
 
 
 
Figure 38: Daglα-depleted embryos have smaller tectal neuropil at 5 dpf. Size 
comparison of the tectal neuropils in 5 dpf scMO injected larvae and daglα 
morphant embryos. The area (in pixels) of the tectal neuropils was measured 
using ImageJ. Data are shown as means ± SEM of 5 independent experiments 
(repeated measures ANOVA ***P < 0.0001). 
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In parallel, we performed pharmacological treatments with CB1 and CB2 
antagonists on 'ath5:gap-gfp' embryos from the stage of 70% epiboly to 5 
dpf. We used two different drug concentrations for CB1 antagonists (2,5 
and 5 μM for AM251; 1 and 2,5 μM for SR141716) and two different drug 
concentrations for CB2 antagonist (AM630: 2,5 and 5 μM). Analyzing 
CB1 antagonists-treated larvae at 5 dpf, we did not reveal any considerable 
abnormalities in the development of the optic nerve. Only in few cases 
(25%) we found some few axons projecting outwardly from the optic 
tectum in larvae treated with the highest concentration of SR141716. No 
external projections in the optic nerve fiber tracts were observed in larvae 
treated with AM251 and AM630 at both concentrations (Fig. 39). 
Nevertheless, comparing tectal neuropil in treated larvae with CB1 
antagonists with control counterparts, we observed that its size was 
significantly smaller on average (Fig. 40). 
These results suggest that 2-AG synthesized by Daglα could have an 
important role in proper retinotectal axon guidance and in correct 
arborization of tectal neuropil, which also requires the activation of the 
CB1 receptor for its complete formation. 
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Figure 39: RGC projections in treated larvae at 5 dpf. Compared to control 
(A), treated larvae did not show any significant defects of RGC axons. (B and D) 
RGCs of animals treated with the highest concentration of AM251 and AM630. 
Only in few cases (25%), we found few axons projecting outside the optic tectum 
(white arrow) in larvae treated with the highest concentration of SR141716 (C). 
 
 
 
Figure 40: Tectal neuropil area in treated larvae at 5 dpf. Comparison of 
tectal neuropil size in 5 dpf control and treated larvae. The area (in pixels) of the 
tectal neuropils was measured using ImageJ. Data are shown as means ± SEM of 
3 independent experiments (repeated measures ANOVA *P < 0,05, **P < 0,01, 
***P < 0.0001). 
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5.13  The role of CB2 in retinal lamination 
To address the question if the ECS could have a role also in retinal 
neurogenesis and eye circuit formation, we took advantage of the zebrafish 
SoFa transgenic line, engineered by the research group led by Prof. W. A. 
Harris, at the University of Cambridge (UK). 
By using SoFa transgenic line it is possible to simultaneously follow the 
differentiation of major neuronal subtypes in zebrafish retina.  
As explained in the Introduction chapter, the zebrafish retina comprises 
five major neuronal types: photoreceptors (PRs), horizontal cells (HCs), 
bipolar cells (BCs), amacrine cells (ACs), and retinal ganglion cells 
(RGCs), and a single type of glial cell, Müller glia. 
To generate a SoFa retina, a combination of three different promoter 
sequences, each driving a different fluorescent protein, was used, so that all 
main subsets of retinal neurons were labelled in distinct spectral 
combinations (Fig. 41): 
1. Atoh7, a bHLH transcription factor, to mark RGCs and labelled with 
gapRFP,  
2. Ptf1a, a bHLH transcription factor, to label retinal inhibitory neurons, 
the ACs and HCs, with cytGFP, 
3. Crx, a homeodomain transcription factor, expressed in BCs and PRs 
and labelled with gapCFP.  
In SoFa retina, gapRFP expression is first detected in the ventronasal retina 
adjacent to the choroid fissure at ∼28-30 hpf. While gapRFP expression 
begins to spread through the retina over the next few hours, expression of 
gapCFP, followed shortly after by the expression of cytGFP, also starts 
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ventronasally and then follows the gapRFP expression around the retina 
until ∼72 hpf (Almeida et al., 2014).  
 
Figure 41: SoFa transgenic line. Reporter protein expression profile and 
corresponding diagram of each of the three transgenes used to generate the SoFa 
line (A-F). Adapted from: Almeida et al., 2014.  
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Thanks to the use of zebrafish SoFa line we examined the consequences of 
genetic and pharmacological manipulations, discovering that treatment 
with 5 μM CB2 antagonist (AM630) from 70% epiboly to 5 dpf led to the 
alteration of retina lamination. In particular, we observed a large number of 
retinal inhibitory neurons retained in the basal RGC layer at 72 hpf and 5 
dpf, instead of a correct positioning in the inner nuclear layer (INL) (Fig. 
42-43).  
The zebrafish retina also contains displaced amacrine cells with their 
somas in the ganglion cell layer immediately adjacent to the inner 
plexiform layer (IPL), towards which they project their dendritic arbors 
(Jusuf and Harris, 2009), but in our experimental treatments the soma of 
Ptf1a-positive cells completely penetrated in the ganglion cell layer.  
Of interest, we didn‟t reveal any significant changes in daglα-MO injected, 
as well as in CB1 antagonist treated SoFa embryos. This may suggest that 
the role of CB2 receptor in the zebrafish retina could be mediated by other 
kind of endocannabinoids different from 2-AG. It remains to be understood 
whether this could be due to a defect of differentiation, proliferation, or 
migration. 
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Figure 42: Trasversal sections of SoFa retina treated with CB2 antagonist at 
72 hpf. A large number of retinal inhibitory neurons are retained in the basal 
RGC layer at 72 hpf (white arrows). 
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Figure 43: Trasversal sections of SoFa retina treated with CB2 antagonist at 
5 dpf. A large number of retinal inhibitory neurons are retained in the basal RGC 
layer at 5 dpf (white arrows). 
 
 
 
 
 
 
 
5 dpf 
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5.14   Generation of zebrafish mutants for daglα and cnr1 by 
CRISPR/Cas9 Technology  
Recently, a new tool based on a bacterial CRISPR-associated protein-9 
nuclease (Cas9) from Streptococcus pyogenes has been generated to make 
precise, efficient and reliable targeted changes to the genome of living 
cells. 
CRISPR-Cas9 technology was adapted from a naturally occurring genome 
editing system in bacteria and archaea as a defense mechanism to silence 
foreign nucleic acids of viruses and plasmids.  
By using this system it is possible to direct site-specific genome editing 
with a small piece of RNA containing a short "guide" sequence (gRNAs) 
that binds to a specific DNA target sequence in a genome. gRNA also 
binds to Cas9 nuclease directing a site-specific DNA cleavage.  
This mechanism generates DNA double-strand breaks (DSBs) in the target 
site, that are then repaired via non-homologous end-joining (NHEJ) 
recombination, resulting in repair errors that generate small insertions and 
deletions (indels) that disrupt the functions of the targeted gene. 
This genome editing technology has provided an accessible tool for 
studying the role of individual genes in the zebrafish model. With regard to 
eCB biology, establishing zebrafish lines with mutations in individual 
genes is indispensable for more precisely studying their function, which 
could be obscured by potential off-target effects associated with 
morpholino and pharmacological investigations.  
Any observed alterations in physiology or behavior could then be linked to 
specific molecular signaling cascades, which could be ideally analyzed 
101 
 
with the use of comprehensive methodologies such as RNA sequencing 
and behavioral assays. 
In our study we decided to produce different zebrafish knock-out lines for 
different genes involved in ECS, starting with daglα and cnr1 in three 
different genetic background (wilde type AB/TL; ath5:gap-gfp transgenic 
line and SoFa transgenic line). 
Gene-specific gRNAs were prepared using the design tool at 
https://chopchop.rc.fas.harvard.edu, which finds and ranks all 23-bp gRNA 
sequences ending in the NGG motif and outputs predictable off-target sites 
on the basis of sequence relatedness.  
We chose two different gRNA for daglα (one targeting a region of coding 
exon 2, one a region of exon 6) and cnr1 genes (both targeting a different 
region of coding exon 1) with no predictable off-target sites. Their 
sequences are presented in Table 6 and their targeting regions illustrated in 
Fig. 44 and 45. 
 
TABLE 6. gRNA sequence 5‟-3‟ 
daglα coding exon 2 GACAACTGACCAAGATGCCG 
daglα coding exon 6 GCTGCTCCGACAGAGACAAC 
cnr1 coding exon 1_a GCTGCGAACGGCTTGGGCAG 
cnr1 coding exon 1_b GCCGATGTACTGCAGGCCGG 
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Figure 44: Representation of gRNAs binding sites in daglα gene. daglα gene 
consists of 20 exons. Sequences for gRNA synthesis, highlighted in orange, have 
been designed on the coding exons 2 and 6, located upstream of the protein 
catalytic domain (alpha/beta hydrolase fold), which starts at exon 8. 
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Figure 45: Representation of gRNAs binding sites in cnr1 gene. cnr1 gene 
consists of just 2 exons interspersed with a short intronic sequence. Both 
sequences for the synthesis of gRNAs, highlighted in orange, have been designed 
on the coding exons 1. 
 
To synthesize template DNA required for the in vitro transcription, we 
employed a two-oligo PCR method (Bassett et al., 2013). 
Zebrafish 1-cell stage embryos were injected with single gRNA and Cas9 
mRNA.  
F0 generation has been allowed to grow for three months and then crossed 
with the wild-type counterpart to select the founder. To this end, genomic 
DNA was isolated from a pool of F1 generation embryos, and gRNA 
binding region was analyzed by Sanger sequencing. 
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Up to now, only SoFa transgenic lines injected with the gRNAs directed 
against daglα gene exons 2 and 6 has been screened. Analyzing F1 
generation by sequencing, we found samples exhibiting mutations both in 
exon 2 and in exon 6, with alteration of the reading frame (Fig. 46-47). 
 
Figure 46: Electropherogram of the daglα mutated exon 2. The presence of 
double peaks indicates an alteration of the reading frame of the analyzed sample. 
 
 
Figure 47: Electropherogram of the daglα mutated exon 6. The presence of 
double peaks indicates an alteration of the reading frame of the analyzed sample. 
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Spontaneous locomotion analysis was conducted on larvae that presented 
the above mutations (Fig. 48), finding that the alterations in both exons led 
to a significant reduction in motility, both in terms of distance moved and 
velocity, thus confirming the data on the locomotor behavioral assay, 
obtained by daglα-MOs. 
 
 
 
 
Figure 48: Locomotion is impaired in daglα CRISPR/Cas9 larvae at 5 dpf. F1 
generation larvae of mutated animals displayed impaired spontaneous movements 
compared with control in term of distance moved (A) and velocity (B). This 
behavioral phenotype was quantitatively assessed by using Ethovision XT 
software analysis. Data are shown as means ± SEM of 3 independent experiments 
(repeated measures ANOVA *P < 0,05, ***P < 0.0005). 
 
  
*** *** * * 
A B 
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6. DISCUSSIONS AND CONCLUSIONS 
 
On the basis of evolutionary and phylogenetic studies, the ECS seems to be 
conserved at least in vertebrates (McPartland et al., 2006).  
Although cnr1 and daglα mRNA expression had been reported in distinct 
areas of zebrafish CNS (Lam et al., 2006; Watson et al., 2008), and 
bioinformatics studies suggested the existence of a complete ECS in this 
species (McPartland et al., 2007), properties and actions of eCB signalling 
during zebrafish development have been subject of only few studies, 
despite clear advantages in using this model organism.  
Here, we investigated the expression profiles of different genes known to 
be involved in endocannabinoid signalling during zebrafish development. 
Our observational gene expression studies contribute to the existing data 
about the endocannabinoid system and emphasize the benefit of this model 
in providing new insights. 
Quantitative PCR analysis revealed that all examined canonical and non-
canonical eCB receptors exhibited a time-dependent increase during 
zebrafish development, which likely reflects a specific modulation of eCB 
levels. Furthermore, substantially different developmental dynamics for 
AEA and 2-AG metabolism were observed. On one hand, genes that code 
for AEA biosynthetic (nape-pld, abhd4) and catabolic (faah) enzymes 
displayed a sequential increase in expression during development. A 
similar pattern was also found for daglα, the gene that encodes the main 2-
AG anabolic enzyme, which exhibited the highest transcriptional increment 
among the examined genes. On the other hand, genes that code for 2-AG 
degradation enzymes (ptgs2b, mgll) showed expression levels that were 
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high in early embryos and decreased during the pre-hatching period that is 
characterized by important changes since hatched fish start new behavioral 
activities in response to free-swimming life and chemical cues (Lindsay 
and Vogt, 2004). 
Zebrafish embryos displayed an active 2-AG turnover, as the Dagls/Magl 
activity ratio increased with developmental time, peaking between 48 and 
72 hpf, which might explain the intense production of 2-AG during 
hatching. Of interest, it has been reported that pharmacologic antagonism 
of CB1 diminishes the hatching rate in zebrafish larvae (Migliarini and 
Carnevali, 2009). Taken together, these data suggest that the specific 
modulation of 2-AG synthesis during the first days of zebrafish 
development can play a role as endogenous stimulation of hatching.  
Moreover, in this study, mass spectrometry analysis revealed that 2-AG 
levels were elevated among others eCBs, and was actively produced during 
zebrafish embryogenesis, suggesting its role as key factor in 
endocannabinoid signalling functions during zebrafish development. 
Using whole-mount in situ hybridization to assess spatial and temporal 
gene expression, we identified CNS areas involved in 2-AG function 
during zebrafish development. We localized daglα, daglβ and mgll 
mRNAs, 2-AG anabolic and catabolic enzymes respectively, and we found 
that the expression of these three genes spatially overlap with that of cnr1, 
the main 2-AG receptor, in defined neuronal sub-populations within all 
main developing brain structures, such as telencephalon, optic area, retinal 
ganglion cells, cerebellum and rhomboencephalon (Fig. 20 F). These 
findings suggest that the 2-AG pathway is required in brain areas that are 
implicated in the control of locomotor and visual functions. Of interest, 
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these genes show also differential expression patterns, hinting that the 
outcome of 2-AG signaling may also be determined by other 
transmembrane proteins or that other monoacylglycerols produced by 
Daglα and other CB receptors might be involved in zebrafish brain 
development (Ahn et al., 2008; Di Marzo, 2011; Di Marzo and De 
Petrocellis, 2012). 
To study developmental functions of the eCB signalling pathway with 
respect to neurogenesis, we addressed the questions of how disruption of 2-
AG biosynthesis impairs axon guidance and behavior, and how 2-AG 
controls development of functional neuronal circuits, as suggested by 
previous studies (Watson et al., 2008, Berghuis et al., 2007). 
We report that 2-AG signaling and eCB receptor activation are required for 
axon growth in the eye and in defined areas of the developing brain, such 
as optic tectum, molecular layer of the cerebellum, and optic chiasm. 
Mechanisms by which ECS exerts its functions are complex and highly 
spatio-temporally and context dependent, but seem to have an impact on 
the motion and vision control. 
We were able to manipulate expression of the zebrafish daglα gene by MO 
technology. Herein, the majority of specific brain regions that express 2-
AG enzymes and receptors (daglα, mgll, and cnr1) show axonal defects in 
daglα morphant larvae.  
It is interesting to note that in the cnr1 zebrafish knockdown, the 
reticulospinal axons of the hindbrain cross abnormally the midline, with a 
failure in the formation of the forebrain anterior and posterior commissures 
(Watson et al., 2008). In the present study, we gained experimental 
evidence that knockdown of the main 2-AG synthesis enzyme, daglα, is 
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associated with a reduced extension of cerebellum fiber length. Although 
apparently opposed by a topographic viewpoint, both 2-AG zebrafish 
models, daglα and cnr1 knockdown, exhibit an aberrant axonal projection 
towards the midline, in support of the hypothesis that 2-AG can act as a 
chemoattractant of axon growth cones and regulates their midline crossing  
(controlaterality). 
Impairment of retinotectal, cerebellar, and facial nerves in Daglα-depleted 
larvae indicates a localized effect on axon guidance and suggests a role for 
2-AG in the development of functional locomotor and visual systems.  
In addition to a central role of ECS in axogenesis and synaptogenesis, 
evidence is accumulating that the ECS mediates visual signalling by 
controlling axon transport and excitability in retinotectal circuitry 
(Ryskamp et al., 2014) and that it plays a role in the initiation and 
coordination of movement by modulating GABA, glutamate, and other 
neurotransmitters throughout the basal ganglia and cerebellum (El Manira 
and Kyriakatos, 2010; Sañudo-Peña et al., 2000). 
In zebrafish, superficial tectal layers receive unprocessed visual 
information from retinal ganglion cells and contribute to larval visual 
system by coordination of eye and body movements via connections with 
cerebellar circuits (Stuermer, 1988; Heap et al., 2013; Gahtan et al., 2005).  
The zebrafish 2-AG knockdown model presented here displays 
compromised processing and/or transmission of visual inputs and motor 
outputs, thus providing a useful system to further investigate the role of the 
ECS in vision and locomotion. Indeed, zebrafish daglα morphants 
generated herein did suffer visual and swimming problems compared with 
uninjected sibling and standard control MO-injected larvae.  
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The consequences of Daglα depletion were that the swimming and visual 
performance was worse in 72 hpf and 5 dpf morphant larvae, respectively, 
compared with controls (Figs. 29 and 32). This closely reflected loss of 
motility (El Manira and Kyriakatos, 2010; Song et al., 2012) and visual 
condition (Ryskamp et al., 2014; Cécyre et al., 2013; Yoneda et al., 2013) 
that has been observed in other vertebrate model organisms.  
The correlation between eCB signaling function and axonal and behavioral 
defects was further established by treatment of morphants with noladin 
ether, a CB1 agonist that differs from 2-AG because it is an ether and not 
an ester, and, as such, it is stable to enzymatic hydrolysis by Magl. 
Consistent with a crucial role exerted by Daglα in 2-AG biosynthesis in the 
brain, we demonstrated that incubation of daglα morphants with noladin 
ether confers partial rescue of axogenesis and spontaneous swimming.  
Since we found that 2-AG reduction is responsible for motility alterations 
we hypothesized that this neuromodulator may play an important role in 
motor control via CB1 and CB2 activation. To validate this assumption, we 
treated zebrafish embryos with CB1 and CB2 receptor antagonists, 
showing that these animals displayed a defective swimming behavior, with 
a lower mean velocity and a lesser distance moved compared to the control 
larvae (Fig. 35-36). Therefore, these data lend support to the hypothesis 
that CB1 and CB2 receptors are needed for the proper function of the 
locomotor system.  
Finally, the axonal outgrowth deficits that we detected here in zebrafish 
daglα morphants, together with the alterations in optokinetic performance, 
prompted us to gain new insight on the ECS role in the correct formation 
of axons in the developing retina and retino-tectal system. 
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For this purpose, we used different transgenic animals that express reporter 
genes in specific classes of neuronal cells and are powerful tools for the 
study of gene expression dynamics and neuronal network formation.  
In the zebrafish transgnic line ath5:gap-gfp it is possible to follow the 
differentiation of retinal ganglion cells (RGCs). 
We analyzed zebrafish 'ath5:gap-gfp' larvae at 5 dpf when the RGC are 
completely formed, finding that dagla-Tb1 MO-microinjected larvae 
showed abnormal optic nerve development, whose axons projected 
abnormally and strayed from the optic nerve before reaching the optic 
tectum (Fig. 37). Moreover, comparing the size of the tectal neuropil we 
observed that it was ~50% smaller on average in morphants than in their 
control counterparts (Fig. 38). 
Furthermore, pharmacological treatments using antagonists suggested a 
putative role of CB1 receptor in the correct formation of the tectal 
neuropile in zebrafish transgenic line 'ath5:gap-gfp'. 
These results lend support to the hypothesis that 2-AG, synthesized by 
Daglα, has an important role in the proper retinotectal axon guidance and 
in correct arborization of tectal neuropil, which also requires the activation 
of CB1 receptor for its complete formation. 
To address the question if the ECS has a role also in retinal neurogenesis 
and eye circuit formation, we took advantage of the zebrafish SoFa 
transgenic line, in which all major retina neuronal subtypes are 
simultaneously labelled. Treatments on zebrafish embryos with a CB2 
antagonist highlighted a potential role in the correct lamination of 
neuroretina, by regulating the positioning of interneurons (amacrine cells) 
in the inner plexiform layer of developing retina. 
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Of interest, we didn‟t reveal any significant changes in daglα-MO injected, 
as well as in CB1 antagonist treated SoFa embryos. This may suggest that 
the effects of CB2 receptor could be mediated by other endocannabinoids, 
different from 2-AG, that are present in the zebrafish retina. It remains to 
be understood whether this could be due to a defect of differentiation, 
proliferation, or migration. 
In conclusion, our results point to the important role of eCBs as mediators 
in axonal outgrowth in defined area of developing brain, with implications 
in the control of vision and movement, highlighting that the well-
established role of 2-AG in axon guidance is required in brain areas that 
control locomotor and optokinetic functions. On the other hand, the eCB 
receptors CB1 and CB2 can specifically regulate the formation of 
retinotectal system, and the differentiation and lamination of zebrafish 
neuroretina, respectively, as well as they are implicated in the control of 
swimming behaviour. 
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7. FUTURE PERSPECTIVES 
In the light of the data obtained so far, our research project is intended to 
continue on the role of the endocannabinoid system in the formation of 
neuronal circuits involved in the development of visual and locomotor 
systems. 
The 2-AG knocking-down phenotype, together with pharmacological 
treatments and the generation of mutant lines, will represent powerful tools 
for understanding the mechanisms of cell fate acquisition, for further 
insights of the specific molecular targets and components of ECS 
signalling mechanisms, and for defining new therapeutic approaches. 
Although zebrafish can significantly advance the understanding of eCB 
biology with the use of pharmacological or genome editing approaches, the 
greatest contribution of this small model vertebrate to the field will likely 
result from studies enabled through combined approaches. 
Any observed alterations in physiology or behavior could then be linked to 
specific molecular signaling cascades, which could be ideally analyzed 
with the use of comprehensive methodologies such as RNA sequencing 
and behavioral assays. 
In conclusion, we propose to investigate the cellular/molecular 
mechanisms downstream of 2-AG signaling, in order to gain new insights 
on the poorly characterized role of the endocannabinoid system in vision 
and locomotion, studying the global dynamics of development and 
particularly the interactions between cell types. This study shows how such 
an integrative approach can be used to shed new light on the acquisition of 
neuronal fates and early steps of cell differentiation. 
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8. MATERIALS AND METHODS  
8.1 Zebrafish maintenance and transgenic fish line 
Zebrafish (Danio rerio) experiments were performed in accordance with 
the European Union animal welfare guidelines [European Communities 
Council Directive of September 22, 2010 (2010/63/ UE)]. Zebrafish were 
maintained according to standard procedures on a 14-h/10-h light/dark 
cycle at 28.5°C, as described previously (Westerfield, 2000). 
Embryos were obtained from our animal colony by natural spawning and 
were maintained in E3 medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM 
CaCl2, 0.33 mM MgSO4, 1x10
–5
% methylene blue) and were staged 
according to hpf and morphologic criteria (Kimmel et al., 1995). In 
particular, embryo euthanasia was performed via hypothermia shock by 
submerging the embryos in ice-cold water for at least 10 min to ensure 
death by hypoxia, or with an overdose of tricaine MS-222 (Sigma, 
E10521). All experiments were conducted on WT embryos at 24, 48, 72 
hpf, and 5 dpf.  
Homozygous Tg(Atoh5:GAP:EGFP) transgenic fishes were generated in 
Harris‟ laboratory: Tg(pBatoh7:gap43-gfp)cb1 ('ath5:gap-gfp'). They 
express a fluorescent protein [enhanced green fluorescent protein (EGFP)] 
fused to the GAP43 N-terminal palmitoylation signal, under the control of 
the zebrafish ath5 promoter (Zolessi et al., 2006). 
The polychrome transgenic line Atoh7:gapRFP/Ptf1a:cytGFP/Crx:gapCFP 
(SoFa) was characterize by William A. Harris‟ group  and were generated 
by crossing following single with double transgenic lines: Atoh7:gapRFP 
(Zolessi et al., 2006), Ptf1a:cytGFP (Godinho et al., 2005), Crx:gapCFP 
(Suzuki et al., 2013), described previously. 
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All transgenic lines were bred each other to obtain transgenic embryos for 
imaging experiments conducted on homozygous embryos at 72 hpf and 5 
dpf. 
8.2 Quantitative PCR analysis 
Embryos and larvae were staged following standard parameters (Kimmel et 
al., 1995). Total RNA was isolated from a pool of 20 animals per group 
using Trizol (Thermo Fisher Scientific, Waltham, MA, USA) and treated 
with DNase I (Thermo Fisher Scientific), and were reverse transcribed with 
the SuperScript III RT reaction kit (Thermo Fisher Scientific) according to 
manufacturer instructions. Of starting RNA, 10-20 ng was used for 
quantitative PCR analysis using IQ SybrGreen Supermix (Bio-Rad, 
Hercules, CA, USA) with primers designed with AlleleID (Table 5) on a 
CFX 384 optical thermal cycler (Bio-Rad). Data analysis was performed 
by using CFXManager software (Bio-Rad) using eef1a1l1 (eukaryotic 
translation elongation factor 1 alpha 1, like 1) as reference gene and was 
expressed as relative mRNA levels with SEM of triplicate reactions. 
Statistical significance was determined with the REST 2009 software 
(Qiagen, Valencia, CA, USA). 
8.3 Measurement of ECs AEA, 2-AG, and EC-like PEA and OEA 
from whole zebrafish 
Eggs, embryos, and larvae were collected at different developmental time 
points. Extraction, purification, and quantification of eCBs were performed 
as previously described (Bisogno and DiMarzo, 2007; Matias et al.,  
2007). In brief, embryos were pestel homogenized and extracted with 
CHCl3/MeOH/Tris-HCl 50 mM, pH 7.5 (2:1:1 vol/vol) that contained 
internal standards ([H]8-AEA 10 pmol; [H]5-2-AG, [H]5-PEA, and [H]4-
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OEA50 pmol each). The lipid-containing organic phase was dried down, 
weighed, and pre-purified by open-bed chromatography on silica gel. 
Fractions were obtained by eluting the column with 99:1, 90:10, and 50:50 
(vol/vol) CHCl3/MeOH. The 90:10 fraction was used for AEA, 2-AG, 
PEA, and OEA quantification by liquid chromatography - atmospheric 
pressure chemical ionization - mass spectrometry by using a Shimadzu 
high-performance liquid chromatography apparatus (LC-10ADVP) 
coupled to a Shimadzu (LCMS-2020) quadrupole mass spectrometry via a 
Shimadzu atmospheric pressure chemical ionization interface (Shimadzu, 
Kyoto, Japan) as previously described (Matias et al., 2007). Amounts of 
eCBs in embryos, quantified by isotope dilution with the above mentioned 
deuterated standards, were expressed as picomols per milligram of protein 
as the weight of the dried organic phase was too low to determine total 
lipid contents. 
8.4 Magl and Dagls enzymatic activity studies on zebrafish embryo 
and larvae 
A pool of 50 embryos/larvae for each time point was homogenized. Once 
we isolated the membrane fraction, 2-AG hydrolysis was measured by 
incubating 100 mg protein/sample in 50 mM Tris-HCl, pH 7, at 37°C for 
20 min with synthetic 2-arachidonoyl-[3H]glycerol properly diluted with 
unlabeled 2-AG. After incubation, the amount of [3H]glycerol produced 
was measured by scintillation counting of the aqueous phase after 
extraction of the incubation mixture with 2 volume equivalents of 
CHCl3/MeOH1:1 (vol/vol). Dagls activity was assessed as previously 
reported (Bisogno et al., 2003) by using the membrane fraction (70 mg 
protein) from the same homogenized sample used for MAGL enzymatic 
117 
 
assay, and 1-[14C] oleoyl-2-arachidonoylglycerol as substrate [1.0 
mCi/mmol, 25mM, synthesized as reported previously (Bisogno et al., 
2003)] in Tris-HCl buffer, pH7, for 20 min. After incubation, lipids were 
extracted with 2 volumes of CHCl3/CH3OH (2:1 vol/vol). Organic 
extracts, lyophilized under vacuum, were purified by using TLC on silica 
on polypropylene plates eluted in CHCl3/CH3OH/NH4OH (85:15:0.1 
vol/vol) as the eluting solvent. Bands corresponding to [14C]oleic acid 
were cut and their radioactivity was measured with a β-counter. Enzymatic 
activities are reported as means of n = 3 experiments. 
8.5 RNA probes production 
Plasmids for synthetizing cnr1 and fgf8a riboprobe were kindly provided 
by Prof. A. Graham (King‟s College-London, UK), and Prof. K. Rohr 
(University of Cologne- Cologne, DE). 
For the riboprobes construction of daglα, daglβ, cnr2, trpv1 and gpr55 
transcripts, the following steps were performed: 
- RNA extraction and cDNA synthesis: 
Whole zebrafish embryos at different stages (24, 48 and 72 hpf) were 
killed with an overdose of tricaine MS-222 (Sigma, E10521) and stored at 
-80°C in 1 ml Trizol® reagent (Thermo Fisher Scientific, 15596018) at 
least for 24 h for RNA extraction. Embryos were defrosted in ice and were 
homogenized using TissueLyser II (Qiagen). For separation phase, 
homogenized sample were incubated for 5‟ at R.T. to permit complete 
dissociation of the nucleoprotein complex. Then, 200 μl chloroform were 
added to homogenates and, after shaking vigorously for 15”, samples were 
incubates for 3‟ at R.T.. After centrifugation, the aqueous phase was 
removed and the RNA purification was performed.  RNA samples was 
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purified using 500 μl phenol/chloroform acid solution and, then, were 
centrifuged to obtain the aqueous phase. RNA samples were precipitated 
with a solution containing 500 μl 100% isopropanol, 30 μl sodium acetate 
and 1 μl glycogen as RNA carrier and were stored for 30‟ at -20°C.  
After centrifugation, RNA pellet was washed in EtOH 70%. Isolated RNAs 
were diluted in 30 μl H2O DEPC and stored at -80°C for further use.  
For cDNA synthesis, 1 μg of RNA was reverse transcribed using 
QuantiTect® Reverse Transcription Kit (Qiagen, 205313) according to 
manufacturer‟s instructions using both oligo (dT) and random primers. 
Synthesized cDNA was stored at -20°C. 
- Amplification of desired DNA fragments and cloning in a suitable 
plasmid 
From the obtained cDNA were generated the template for daglα, daglβ, 
cnr2, trpv1 and gpr55 transcripts by PCR using the following primers: 
Gene Forward 5’-3’ Reverse 5’-3’ 
daglα CTTCAGTTTCAGGCTCTCGC GCACTTTGTTCCTCCAGCAA 
daglβ GTTTTGACGGATCTCTCGGC GGATGATGGGCAGAGGGTAA 
cnr2  CAGTGACTTTCCTGGCGAAC GCCTGTCTGCACTCCTAGAA 
gpr55 CCAACTCATCGACAGACTGTGA TCGCCATTCTCCTCTCTTTCTG 
trpv1 ATGCTGCTTACACCGACAGTTA TCGCGTAATCCTTCCCTTCTTC 
 
A zebrafish full-length mgll clone was obtained from an I.M.A.G.E. cDNA 
plasmid clone (IRBOp991A0923D) into the pME18S-FL3 vector (Unigene 
DR.106158; Entrez Gene 378960 – Source  BioScience  LifeScience). 
This clone was amplified by PCR using the following primers for the 
subsequent subcloning: 
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Forward 5‟-3‟: GATTTCTGCCTCCAGCATTCAGCCTG 
Reverse 5‟-3‟: TAAAGTAGAGATGTGATTGGACAGGGG. 
All the obtained fragments were subcloned into pCR™II-TOPO® vector 
(Invitrogen) according to manufacturer‟s instructions, and the sequences 
and insertion directionality were checked for automatic sequencing for 
capillary electrophoresis at the Molecular Biology and Bioinformatics Unit 
(Stazione Zoologica Anton Dohrn – Napoli), by using Applied Biosystems 
(Life Technologies) 3730 Analyzer 48 capillaries. 
- Digoxigenin-labeled antisense riboprobes synthesis 
To produce digoxigenin and fluorescein (fgf8a) – labeled antisense 
riboprobes, the templates were linearized and transcribed with the 
appropriate restriction enzyme and RNA polymerase (Table 7). 
 
TABLE 7: ENZYMES for ANTISENSE RIBOPROBES 
PRODUCTION 
TEMPLATE RESTRICTION ENZYME RNA POLYMERASE 
daglα NotI Sp6 
daglβ NotI Sp6 
mgll KpnI T7 
cnr1 EcoRV Sp6 
trpv1 EcoRV Sp6 
cnr2 NotI Sp6 
gpr55 EcoRV Sp6 
fgf8a XhoI T7 
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8.6 Whole mount in situ hybridization (WISH) 
WISH analyses were performed as previously described (Westerfield, 
2000). Briefly, zebrafish embryos at different stages (24, 48 and 72 hpf) 
were anaesthetized with tricaine MS-222 and fixed in 4% paraformaldeide 
(PFA) overnight at 4°C. Larvae were washed in 1X PBS 3 times 10 
minutes and dehydrated in a MeOH series for storage in 100% MeOH at -
20°C until further use. Embryos were rehydrated stepwise in methanol ⁄ 
PBS and finally put back in PBT (PBS 1X Tween 0,1%). 
Samples were incubated in proteinase K (10μg/ml in PBT) for 5‟ (24 hpf), 
15‟ (48 hpf), 30‟ (72 hpf). Reactions were stopped by rinsing in PBT 
followed by post fixation in 4% PFA in 1X PBS for 20 min at R.T. and by 
rinsing four times in PBT. Zebrafish embryos were pre-hybridized for 3 h 
at 63°C in hybridization buffer and, then, they were incubated O.N. in the 
hybridization solution containing 200 ng of the probe at 63°C (probe was 
denatured for 10 min at 95°C). The probes were removed by 30‟ step-wise 
washes in 100, 75, 50 and 25% hybridization buffer and 2X SSC, in 2X 
SSC for 10‟, in 0.2X SSC for 30‟, in 10 mM PIPES and 0.5 M NaCl for 
10‟ and, finally, in maleic buffer tween-20 (MBT). Subsequently, zebrafish 
embryos were incubated in 2% Roche Blocking Reagent (Roche Applied 
Science, code 11096176001) for 2 h and, then, left in Fab fragments from 
polyclonal anti-digoxigenin antibodies, conjugated to alkaline phosphatase 
(Anti-Digoxigenin-AP, Fab fragments, Roche Applied Science, code 
11093274910) at a 5.000-fold dilution in blocking reagent O.N. at 4°C. 
After several washes in MBT, embryos were incubated in a staining buffer 
and, then, in BM Purple chromogenic substrate (Roche Applied Science, 
code 11 442 074 001) until staining was sufficiently developed. After 
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stopping the reaction, embryos were post fixed in 4% PFA in 1X PBS for 
20‟ and, finally, stored in 95% glycerol at 4°C. 
Double-fluorescent WISH was performed as previously indicated (Brend 
and Holley, 2009). 
Whole mount chromogenic zebrafish samples were imaged on a Zeiss 
AxioImager.M1 microscope with 10X or 20X objective. Whole mount 
fluorescent zebrafish preparations mounted on slides were imaged on a 
Zeiss LSM 710 laser scanning confocal microscope with 20X objective. 
Excitation and emission wavelengths were set according to the fluorophore 
used. All experiments were conducted in triplicates. 
8.7 MO knockdown 
- Zebrafish embryo injection 
MO injection was used to block specific gene translation. For daglα and 
mgll knockdown experiments, antisense MO oligonucleotides designed to 
bind to the start codon (dagla-Tb1 and mgll-Tb1), to the daglα exon 3 
splice donor site (dagla-Sb1), and to the mgll exon 2 splice donor site 
(mgll-Sb1) were purchased from Gene Tools (Philomath, OR, USA). MO 
sequences were as follows:  
dagla-Tb1: 5‟ – TGCCCGGCATCACTGCCCTGAAACA – 3‟;  
dagla-Sb1: 5‟ – GTGTTCACAGTGTACGTCTTACCTA – 3‟;  
mgll-Tb1: 5‟ – CATGTCCCCGCTGAGGGTTGAGTCA – 3‟;  
mgll-Sb1: 5‟ – TATGTCATCTCACACTTACTTCGGA – 3‟.  
Upon receiving lyophilized MOs, a 1 mM stock solution in sterile water 
was prepared and stored at -20°C. Titration of MOs to find effective 
concentrations is shown in Fig. 23. Wildtype zebrafish were injected into 
the yolk at 1–2 cell stages with desired MO concentration (300 μM) in 
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sterile water using phenol red at 0.05% as an injection indicator. Control 
embryos were injected with standard control MO (300 μM). 
Embryos were lined up on a plastic dish against a glass slide in a medium-
free environment. Injections were performed using 0.78 mm needles pulled 
with a needle puller (1.0 mm OD × 0.78 mm, Harvard Apparatus; puller: 
Pul-1, World Precision Instruments) and 1 nl of volume was pressure 
injected using an air-pressure injector (Picospritzer II; Intracel). 
For RT-PCR analysis of dagla and mgll splicing products after MO 
injection, total RNA was isolated from a pool of 100 embryos at 24 hpf 
using Trizol (Thermo Fisher Scientific) and was reverse transcribed with 
QuantiTect Reverse Transcription Kit (Qiagen), as described above. 
Primers were designed in exon 3 and exon 4 of daglα: 
forward: 5‟-CGAGAGCGCCATCATGTGGC-3‟ 
reverse: 5‟-CGAGGGCGAGGTTCTTAGCG-3‟  
and in exon 2 and exon 3 of mgll: 
forward: 5‟-ATGCCGGAACCGAGGGACT-3‟ 
reverse: 5‟-CGTGGTCGTGGCGAACACCA-3‟.  
1 μg of cDNA was amplified for RT-PCR analysis and reaction conditions 
were performed as follows: 95°C for 5 min, followed by 30 cycles of 95°C 
for 1 min, 55°C for 1 min, 72°C for 1 min, and a final extension step of 
72°C for 10min. PCR products were visualized by using 1.5% agarose gel 
electrophoresis, subcloned into pCR™II-TOPO® vector (Invitrogen), and 
then subjected to automatic sequencing for capillary electrophoresis at the 
Molecular Biology and Bioinformatics Unit (Stazione Zoologica Anton 
Dohrn – Napoli), by using Applied Biosystems (Life Technologies) 3730 
Analyzer 48 capillaries. 
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8.8 Pharmacological treatments and exposure windows 
To perform dose-response curve in order to identify sub-lethal drug 
concentrations, six groups of 30 fertilized eggs were placed in individual 
wells of 6-well plate. The AM251 (Tocris, 1117/1), SR141716 (Tocris, 
0923/10), AM630 (Tocris, 1120/10) treatment began at 7 hpf until 5 dpf. 
Each group was exposed to 0,5 μM, 1 μM, 2,5 μM, 5 μM, and 10 μM. An 
untreated control group of 20 fertilized eggs was examined in parallel. For 
each group (control and treated) DMSO at final concentration of 0.1% was 
added. Observations for any developmental effects due to treatment were 
made at 24, 48, 72 hpf and 5 dpf. Mortality and morphological deformities 
of embryos were recorded and photographed. Dead embryos were removed 
immediately once observed. Test drug solutions were renewed daily. Once 
we have selected the sub-lethal drug (10 μM for AM251 and AM630, 5μM 
for SR141716) concentrations for our study, groups of 30 fertilized eggs 
were exposed to drug treatments from 7 hpf until to 5 dpf. The above-
mentioned experiments were performed in biological triplicates. 
8.9  Whole mount immunohistochemistry 
Immunostaining was done by using standard whole-mount immunostaining 
protocol with Vectastain elite ABC kit (Vector Laboratories, Burlingame, 
CA, USA) (Westerfield, 2000). Zebrafish larvae at 72 hpf were 
anaesthetized with tricaine, MS-222, and fixed in 4% paraformaldeide 
(PFA) overnight at 4°C. Larvae were washed 3 times in 1X PBS for 10 
minutes and dehydrated in a MeOH series for storage in 100% MeOH at -
20°C until further use. Animals were rehydrated stepwise in methanol⁄PBS, 
and then putted in PBS-Triton 0.8%. To remove pigmentation, zebrafish 
larvae were bleached with a bleaching solution containing potassium 
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hydroxide and hydrogen peroxide for 30‟. Samples were, then, 
permeabilized with proteinase K (10μg/ml) for 30‟ at RT, washed in in 
PBS-Triton 0.8% and post- fixed in PFA for 20‟. Larvae were incubated 
with blocking solution of 5% normal horse serum (NHS) for 1 h at R.T. on 
a shaker. Samples were incubated O.N. in blocking solution containing the 
monoclonal anti-acetylated tubulin primary antibody (Sigma-Aldrich, St. 
Louis,MO, USA) at 1:1000 concentration. After several washes in PBS-
Triton 0.8%, samples were incubated with an hydrogen peroxide solution 
diluted in MeOH to block endogenous peroxidases and, then, with an anti-
mouse IgG biotinylated secondary antibody (1:200), diluted in blocking 
solution O.N. at 4°C on shaker.  
After several washes in PBS-Triton 0.8%, samples were incubated with 
avidine-biotine solution (Vectastain ABC kit, PK6102) and, finally, the 
incubation with the chromogenic substrate 3,3‟-diaminobenzidine (DAB) 
was performed according to manufacturer instructions. For DAB detection, 
1 μl of 0.6% H2O2/ml DAB solution was added, until staining was 
sufficiently developed. For detailed analysis, embryos were postfixed in 
4% paraformaldehyde for 20 min at room temperature, washed in PBS that 
contained 0.1% Tween 20, and gradually transferred to 90% glycerol and 
stored at 4°C. Whole mount chromogenic zebrafish samples were imaged 
by using a Zeiss AxioImager.M1 microscope equipped with Axiocam 
digital camera (Zeiss) with 10X or 20X objective.  
To detect and quantify superficial neuropil layer (SNL) axons, a manual 
counting was performed. Statistical significance of axon phenotype 
measurements was determined with Prism (version 6; GraphPad Software, 
La Jolla, CA, USA). Statistical analysis was performed by using Kruskal-
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Wallis test followed by Dunn‟s multiple comparison test. All experiments 
were conducted in triplicates. 
8.10 Optokinetic response 
Large-field movements in the visual environment induce spontaneous, 
compensatory eye movements known as optokinetic responses (OKRs). In 
brief, larvae [5 days post fertilization (dpf)] were embedded in 3% pre-
warmed (28°C) methylcellulose in a Petri dish to prevent body movements 
without affecting eye movements. The Petri dish was surrounded by a 
drum screen, upon which computer-generated stimulus patterns can be 
projected (PLV-Z3000; Sanyo, Moriguchi, Japan). Stimulus patterns 
consisted of vertical black-and-white sinusoidal gratings rotating around 
the larvae. Larvae were illuminated by infrared emitting diodes (peak 940 
nm, BL0106-15-28; Kingbright, Taipei, Taiwan) from below and were 
recorded by an infrared-sensitive CCD camera (GuppyF-038B NIR; 
AlliedVision, Exton, PA, USA) from above. To determine contrast 
sensitivity, a spatial frequency of 20 cycles/360° and an angular velocity of 
7.5°/s were applied with varying contrast (5, 10, 20, 40, 70, and 100%). To 
examine spatial sensitivity, an angular velocity of 7.5/s and 70% of 
maximum contrast was applied with varying spatial frequency (7, 14, 21, 
28, 42, and 56 cycles/360°). To explore temporal sensitivity, maximum 
contrast and a spatial frequency of 20 cycles/360° were applied with 
varying angular velocity (5, 10, 15, 20, 25, 30°/s). Data were analyzed and 
figures were prepared by SPSS (version 22.0; Chicago, IL, USA). 
8.11 Locomotor assays 
Locomotor analysis was performed using Noldus EthoVision DanioVision 
(Noldus, Leesburg, VA, USA) technology, a fully automated, high-
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throughput system designed for quantitative analysis of locomotory 
performance. It consists of an observation chamber, a high-quality digital 
camera, and Etho-Vision XT software. Fish larvae (72 hpf and 5 dpf) were 
placed one-per-well in a 96-well plate with clear bottoms in pre-warmed 
(28°C) E3 medium. Locomotion was observed using the lightON/lighOFF 
protocol. After an adaptation period of 10 min to a LED illumination 
source used to provide an even distribution of light across the multiwell 
plate, larvae were subjected to a light stimulus with 100% white light 
intensity for 10 min, after which they were returned to a condition of 
darkness for other 10 min. This repeated 2 times. Tracking duration was 50 
min. All experiments were conducted in a room separate from the main 
zebrafish facility and the presence of the experimenter in the recording 
room was limited to the initial minute of recording in order to minimize 
extraneous stimuli. All videos were recorded between the 10:00 am and 
2:00 pm. For the recording of movements and post-experimental data 
processing, movement was recorded and automatically analyzed by the 
EthoVision XT software package. All recording and analysis were 
achieved in real time. Data analysis enables immediate recognition of 
parameters, such as total distance moved and mean velocity. Locomotor 
parameters were calculated for 12 embryos per group and over three 
different video acquisitions, and averaged for each treatment.  
8.12 Transgenic lines imaging 
Atoh5:GAP:EGFP zebrafish transgenic line morphological analysis was 
done at 5 dpf, when the tectum is fully innervated. MO-injected and 
pharmacological treated zebrafish embryos were fixed with 4% PFA and 
then rinsed 3 times in 1X PBS at 5 dpf and kept at 4°C for a minimum of 
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24 h. For visualization of labeled axons, both eyes were removed using 
dissection pins and larvae were mounted laterally in a custom-made glass 
bottom dish in 1.2% low-melting-point agarose (24–28°C gelling point; 
Promega). Images were acquired using a PerkinElmer Spinning Disk 
UltraVIEW ERS; Olympus IX81 Inverted confocal microscope, and 30X 
UPLSAPO objectives (NA 1.3) water-immersion objective. Images were 
analyzed using Volocity 3D Image Analysis Software 
(RRID:SCR_002668; PerkinElmer).  
SoFa zebrafish transgenic line morphological analysis was done at 3 and 5 
dpf, when the retina is fully differentiated. Zebrafish larvae were fixed for 
3 h in 4% PFA at RT, rinsed 3 × in 1X PBS, and put in 30% sucrose in 1X 
PBS over night. Embryos were embedded in Tissue-TEK OCT compound 
(SAKURA) and quick frozen on dry ice or at -80°C. Transverse retina 
sections with a 20 μm thickness were cut using a cryostat (CM3050S; 
Leica) 
Slides were washed 3 × 10 min in PBS, drained off, and mounted with 
FluorSave reagent. All slides were imaged using a PerkinElmer Spinning 
Disk UltraVIEW ERS; Olympus IX81 Inverted microscope, and 30X 
UPLSAPO objectives (NA 1.3) water-immersion objective. Images were 
analyzed using Volocity 3D Image Analysis Software 
(RRID:SCR_002668; PerkinElmer).  
8.13 Genome Editing using CRISPR/Cas9 Technology 
- sgRNA design and template synthesis 
sgRNAs were designed using the design tool at 
https://chopchop.rc.fas.harvard.edu, which finds and ranks all 23-bp 
sgRNA sequences ending in the NGG motif. It also outputs predictable off-
128 
 
target sites on the basis of sequence relatedness. Because of a restriction of 
the T7 RNA polymerase in our synthesis, only sgRNAs that began with a 
5′ G nucleotide were chosen. To synthesize the template DNA required for 
the in vitro transcription, we employed a two-oligo PCR method (Bassett et 
al., 2013). First, an oligo scaffold containing the RNA loop structure 
required for recognition by Cas9 was synthesized; this was common to all 
of the sgRNAs generated. Next, a unique oligo containing a T7 binding 
site, the 20 nucleotides specific to the sgRNA and 20 bases of homology to 
the scaffold oligo was synthesized. PCR was performed using these two 
oligos such that they templated off each other and the full sgRNA sequence 
was created. The scaffold oligo sequence was: 5′ - 
GATCCGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGAC
TAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAAC – 3′ and the 
gene-specific oligo sequence was 5′-
AATTAATACGACTCACTATA(N20)GTTTTAGAGCTA GAAATAGC-
3′, where (N20) refers to the 20 nucleotides of the sgRNA that bound the 
genome (excluding the NGG motif, Table 6). The full-length PCR product 
then was 5′-AATTAATACGACTCACTATA (N20) 
GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTT
ATCAACTTGAAAAAGTGGCACCGAGTCGGTGCGGATC-3′. The 
PCR reaction included 2.5 µL H2O, 12.5 µL 2X Phusion Master Mix (New 
England BioLabs, M0531L), 5 µL scaffold oligo (10 µM, synthesized at 
Sigma-Aldrich), and 5 µL sgRNA oligo (10 µM, synthesized at Sigma-
Aldrich) and was run in a thermocycler under the following program: 95°C 
for 30 s; 40 cycles of 95°C for 10 s, 60°C for 10 s, and 72°C for 10 s; and 
72 °C for 5 min. This PCR product was purified and used as a template for 
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the in vitro transcription reaction. All DNA purifications were performed 
on columns (Zymo Research, D4014). 
- RNA in vitro transcription for sgRNA and Cas9  
For synthesis of Cas9-encoding mRNA, we used pT3Ts-nCas9n from the 
Chen lab, obtained via Addgene (46757). The plasmid was linearized using 
XbaI (New England BioLabs, R0145S), and DNA was purified. 1 µg of 
linear plasmid was used in an in vitro transcription reaction (T3 mMessage 
mMachine, Life Technologies, AM1348M). For sgRNA synthesis, 1 µg of 
guide-template PCR product was used in a T7 in vitro transcription half-
reaction (MEGAscript T7, Life Technologies, AM1334M). Both RNA 
products were cleaned by column (Zymo Research, R1016). A Nanodrop 
spectrophotometer was used to ensure purity and check concentrations. 
- Injection of Cas9-encoding mRNA and sgRNA 
All injections contained 500 ng/µL Cas9-encoding mRNA. All sgRNAs 
were diluted to 50 ng/µL. 1 nL of Cas9-sgRNA mix was used for all 
injections. 
- DNA isolation and screenening 
A pool of 10 embryos of F1 generation was lysed in NTES solution (Tris 
pH 8.0 50 mM; EDTA pH 8,0 50 mM; NaCl 0,1M; SDS 10%) plus 0,3 
U/mg of proteinase K solution (Roche PCR Grade recombinant Cat 3 115 
828), rotated and heated at 55°C over night. The digested material was 
spinned at 13,000 rpm for 5‟ to separate skin from digested tissue. At the 
supernatant were added saturated NaCl and vortexed aggressively for 10-
30 sec, and then spinned for 10‟ at 13,000 rpm. The supernatant was 
transferred in absolute ethanol and inverted a sufficient number of times to 
obtain maximum concentration of the precipitate DNA mass. The DNA 
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was spulled out and washed in 70% ethanol, and finally dissolved in Milli-
Q water at 60°C for 10‟. 100 ng of genomic DNA were then used for PCR 
amplification. We amplified by PCR the gRNA target region of daglα exon 
2 and exon 6 with the following primers: 
daglα exon 2 forward: 5‟ – ATTGTCCCTTTGTGTTCCAAAT – 3‟ 
daglα exon 2 reverse: 5‟ – TCTGGGTTGTGTGTAGAGGATG – 3‟ 
daglα exon 6 forward: 5‟ – CTTACTCTGAGGTTGCCAGCTT – 3‟ 
daglα exon 6 reverse: 5‟ – CTAAACCCACGATTTTGCAGAC – 3‟. 
The PCR products were then purified by QIAquick PCR Purification Kit 
(QIAGEN) according to manufacturer‟s instructions, and the sequences 
were checked for automatic sequencing for capillary electrophoresis at the 
Molecular Biology and Bioinformatics Unit (Stazione Zoologica Anton 
Dohrn – Napoli), by using Applied Biosystems 3730 Analyzer 48 
capillaries (Life Technologies), to check if there were mutations and thus 
recognize the founders. 
8.14 Statistical analyses 
For multiple group comparisons, either Kruskal-Wallis or 1-way ANOVA 
tests were used. The significance of differences between 2 unpaired groups 
was determined by Student‟s t test. P < 0.01 or P < 0.05 was taken as a 
minimum level of significance. Data are expressed as means ± SEM or SD.  
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